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An intervention that consistently extends maximal life span is caloric 
restriction (CR), but its application in humans is not practical. A more feasible 
approach is to develop a CR mimetic that targets biochemical pathways 
affected by CR, and thus achieve life span extension. Polyketides and 
alkaloids are structurally diverse secondary metabolites produced by 
microorganisms and plants. Some of these compounds have important clinical 
uses, while others are known to have bioactive properties that range from anti-
oxidant, anti-microbial to anti-aging activities. By establishing a combinatorial 
biosynthetic route in Escherichia coli and exploring the substrate promiscuity 
of a mutant polyketide synthase (PKS) from alfalfa, many potential anti-aging 
polyketides and alkaloids can be biosynthesized. In this approach, novel acyl-
CoA precursors including nitrogen-containing precursors generated by various 
promiscuous acid-CoA ligases will be delivered to the mutant PKS, and the 
polyketides and alkaloids thus generated will be introduced to Caenorhabditis 
elegans when they feed on the engineered E. coli. A molecular screening 
platform where compound libraries are screened in C. elegans-based life span 
assays can thus be developed. Mitochondrial function assays were also 
adopted to look at the mitochondrial activity of C. elegans when they were 
exposed to potential CR mimetics. It was found that CR mimetics like 
resveratrol can counter the age-associated decline in mitochondrial function. 
This study highlights the utility of synthetic enzymology in anti-aging studies, 
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CHAPTER 1: INTRODUCTION 
 
1.1  Metabolic networks of longevity 
Aging is a major risk factor for many diseases such as stroke, cancer, and 
Alzheimer’s disease (Martin, 2011). Given existing demographic trends and 
the associated health care expenditure of aging societies (Olshansky et al., 
2009), there is a pressing need to focus biomedical research efforts in the 
biology of aging. The first biochemical genetic pathway able to modulate the 
life spans of several organisms was inspired when Johnson and Freidman 
succeeded in mapping the first “longevity gene”, age-1, in the 1980s 
(Friedman and Johnson, 1988).  
A mutation in age-1 in Caenorhabditis elegans was found to extend their 
mean and maximal life span. Further research in the subsequent years led to 
the finding that age-1 encoded the catalytic subunit of  phosphatidylinositol-3-
OH kinase (PI3K) (Morris et al., 1996) which could negatively regulate a 
downstream forkhead transcription factor, DAF-16 (Dorman et al., 1995). 
DAF-16 controls the expression of antioxidant scavenger genes such as 
manganese-dependent superoxide dismutase (MnSOD) in C. elegans (Honda 
and Honda, 2002), explaining why age-1 mutants are more resistant to free 
radicals and thus, possibly leading to a longer life span (Martin, 2011). 
Mutations in DAF-2, an insulin-like growth factor (IGF) receptor homologue 
that is upstream of age-1, also resulted in increased MnSOD levels and life 
span extension in C. elegans (Honda and Honda, 2002). This constitutes the 
insulin/IGF-1, PI3K pathway, and suppression of this nutrient-sensing 




(Tissenbaum and Ruvkun, 1998; Tatar et al., 2001). In addition, rising interest 
in the field of aging sparked a series of new discoveries in two other areas, 
namely the role of telomerase in replicative senescence, and stem cells and 
regenerative medicine (Martin, 2011). 
Though the theories of aging are rather well established, the knowledge 
regarding how we can prevent or delay aging is still limited. This is due to the 
fact that none of these theories are considered sufficient to explain the 
mechanism of aging, as aging is a very complex process that is not likely to be 
elucidated by a single pathway (Houtkooper et al., 2010; Cesari et al., 2013). 
Furthermore, aging encompasses diverse changes in various parts of the body, 
and at different biological levels of organization such as macromolecules, 
organelles, cells, and tissues (Gems and Partridge, 2013). Currently, nine 
hallmarks have been proposed to contribute to the aging phenotype, namely 
genomic instability, telomere attrition, epigenetic alterations, loss of 
proteostasis, mitochondrial dysfunction, deregulated nutrient sensing, altered 
intercellular communication, stem cell exhaustion, and cellular senescence 













Figure 1.1: Aging is a very complex process that is characterized by nine 
hallmarks. 
 
The average human life expectancy has increased substantially over the 
last century, but this increase is attributed to large-scale improvements in 
human nutrition and environmental factors, and the breakthroughs in 
preventive and therapeutic medicine (Vendelbo and Nair, 2011). While drug 
interventions have largely improved the quality of life in numerous patients 
and effectively extended life span, limited interventions exist which focus on 
the increase of maximal life span in relatively healthy subjects (Gems and 
Partridge, 2013). Humans are still relatively helpless with regards to the 
numerous damaging cellular changes that eventually result in a senescent 




consistently extended maximal life span in various healthy animals is caloric 
restriction (CR) (Lanza and Nair, 2010; Cesari et al., 2013). In recent years, 
many studies have suggested that longevity is intrinsically related to 
metabolism, and this will be further expounded upon in this thesis. 
 
1.2   Caloric restriction and its role in anti-aging 
The anti-aging effects of CR were first discovered in 1935 through 
experiments on rats (McCay et al., 1935), but research interest in longevity 
has only gained momentum in recent decades. Currently, CR is defined as a 
reduction of caloric intake by 30 – 40% of ad libitum consumption, without 
causing malnutrition (Lanza and Nair, 2010). It is thought that CR can cause 
life span extension in model organisms by triggering a shift from a 
physiological state of proliferation and growth, to repair and maintenance. In 
particular, studies have shown that CR can reduce oxidative damage, retard 
age-related functional decline such as deteriorations in DNA repair capacity, 
and cause a 30 – 40% increase in maximal life span of mammals (Weindruch 
et al., 1986; Walford et al., 1987; Sohal and Weindruch, 1996). 
Other than the insulin/IGF-1 pathway which is involved in nutrient-
sensing, three other interconnected nutrient-sensing systems have been 
identified to play a role in CR (Kenyon, 2010). The mechanistic target of 
rapamycin (mTOR) kinase is important for sensing high amino acid 
concentrations and regulates anabolic metabolism. Reduction of mTOR 
activity by ribonucleic acid interference (RNAi) was found to increase 




span independently of the FOXO (forkhead box O) transcription factor in C. 
elegans (Jia et al., 2004). On the other hand, low energy states can be sensed 
by 5’-Adenosine Monophosphate-activated Protein Kinase (AMPK) and 
sirtuins via detection of high 5’-Adenosine Monophosphate (AMP) levels, and 
high oxidized Nicotinamide Adenine Dinucleotide (NAD+) levels respectively, 
thus playing a role in the regulation of catabolic metabolism such as fatty acid 
oxidation (Lopez-Otin et al., 2013). Interestingly, supplying the anti-diabetic 
drug metformin to mice can activate AMPK (Zhou et al., 2001) and lead to 
life span extension (Anisimov et al., 2008). However, metformin has potential 
adverse effects such as gastrointestinal problems in humans (Bolen et al., 
2007), and more studies are needed to test the anti-aging effects in humans 
(Anisimov, 2013). Increasing NAD+ levels by inhibiting NAD+ breakdown or 
supplying NAD+ precursors, can also delay aging in model organisms 
(Mouchiroud et al., 2013). 
A diet low in calories, while maintaining essential nutrient intake, can 
increase maximal life span by triggering nutrient sensors such as reducing 
IGF-1 and mTOR signaling, and activating AMPK, sirtuins and other NAD+-
dependent mechanisms to promote energy production (Moroz et al., 2014) 
(Figure 1.2). This will in turn activate the transcriptional coactivator PGC-1α 
(peroxisome proliferator-activated receptor gamma coactivator-1-alpha) and 
certain transcription factors like FOXO, which are involved in mitochondrial 
biogenesis (Finley et al., 2012), promoting fat mobilization from white 
adipose tissue to blood (Guarente, 2013), and regulating oxidative stress 
responses (Houtkooper et al., 2010). CR has also been found to maintain 




(Wang et al., 2015). Short term studies in humans have suggested health 
benefits like better lipid profiles and insulin sensitivity (Walford et al., 2002), 
while a 3- to 15-year CR diet in humans showed additional benefits such as 
lowered levels of inflammation markers, and reduced risk of atherosclerosis 
and heart disease (Fontana et al., 2004; Stein et al., 2012). 
 
Figure 1.2: Overview of the insulin/IGF-1 signaling pathway and its 
relationship to CR and aging. Molecules which play a role in anti-aging when 
activated, are shown in light pink. GH: Growth hormone; PTEN: Phosphatase 
and tensin homolog.  
 
Some studies have suggested that CR causes an overall effect of slowed 
metabolic rate and reduced mitochondrial reactive oxygen species (ROS) 
production on the host organism, thus bringing about life span extension 
(Sohal and Weindruch, 1996; Heilbronn and Ravussin, 2003). However, there 
is increasing evidence which supports the view that CR generates ROS, 
resulting in a small increase in oxidative stress, and yet promoting longer life 
span. This is because CR reduces caloric intake, which in turn causes 
metabolism to shift away from glycolysis towards respiration in order to 




an elevated electron transport, respiration, and ROS production. This low 
exposure to a greater oxidative stress triggers a secondary adaptive response in 
the host’s defence system, leading to better stress resistance and life span 
extension (Houthoofd and Vanfleteren, 2006; Schulz et al., 2007; Kim et al., 
2015). This contrary effect to a potentially harmful stressor is termed 
mitohormesis.  
Nevertheless, the regimented use of CR to improve life span in humans 
has not been conducted for long periods of time due to difficulties in adhering 
to such a rigorous intervention, and ethical issues (Heilbronn and Ravussin, 
2003; Gems and Partridge, 2013). Moreover, there are potential adverse 
effects such as depression, bone thinning, slowed wound healing, and 
hypotension (Finkel and Holbrook, 2000; Dirks and Leeuwenburgh, 2006). 
The amount and duration of CR necessary to extend life span is not practical 
in humans (Dirks and Leeuwenburgh, 2006). Hence, the key lies in developing 
a CR mimetic that can directly target biochemical pathways affected by CR, 
and achieve life span extension (Ingram et al., 2006). Discovery of anti-aging 
drug leads is a promising and expanding research endeavor warranting more 
effort from researchers. 
 
1.3  Caenorhabditis elegans as a model organism 
In the search for an anti-aging compound, various model organisms such 
as Escherichia coli, budding yeast, C. elegans, Drosophila melanogaster, and 
mouse, have been used by different researchers. The soil-dwelling nematode 
C. elegans is a small, transparent, free-living roundworm which feeds on 




hermaphroditic, producing up to 300 clonal progeny during the first week of 
their adult life. C. elegans is a eukaryote simple enough to be studied in great 
detail because the developmental fate of every single somatic cell (959 in the 
adult hermaphrodite) has been mapped out (Gruber et al., 2009). Hence, it is a 
model of choice for many investigators researching on developmental 
pathways, neurobiology, aging and antioxidant mechanisms. C. elegans 
provides a powerful metazoan model for studying longevity because it has a 
short life span of approximately three weeks at 20°C, is easily maintained 
under laboratory conditions, and is amenable to genetic modification of 
processes that might be essential in mammals. Furthermore, numerous age-
associated changes seen in mammals are recapitulated in C. elegans, including 
deteriorations in cellular components like mitochondria, and declines in 
physiological functions like locomotion and sensory behavior (Maglioni et al., 
2014). 
As such, many anti-aging studies have been conducted on C. elegans, 
consistently proving that CR extends life span (Klass, 1977; Greer and Brunet, 
2009). CR in C. elegans has been shown to increase metabolic rate, which is a 
key element in CR-induced longevity in C. elegans (Bishop and Guarente, 
2007; Schulz et al., 2007; Greer and Brunet, 2009; Gruber et al., 2009). A 
study carried out by Yuan and colleagues examined metabolism in C. elegans 
eat-2 mutants, which have a pharyngeal pumping defect leading to 
compromised food intake (Lakowski and Hekimi, 1998), allowing mutants to 
undergo chronic CR and subsequently life span extension. By using a 
quantitative proteomic analysis of key proteins involved in energy metabolism 




fructose-1,6-bisphosphatase, short-chain fatty acid-specific acyl-CoA 
dehydrogenase, and  enoyl-CoA hydratase, it was found that carbohydrate 
metabolism was reduced, while short-chain fatty acids replaced carbohydrates 
as the main energy source in these mutants (Yuan et al., 2012). In addition, 
eat-2 mutants had a 21-fold higher rate of oxidative metabolism of acetate, 
and had an approximately 30% longer life span compared to the wild-type.  
Similarly, reducing glucose metabolism of wild-type C. elegans using 
glycolysis inhibitors or RNAi increased lipid metabolism, resulting in greater 
mitochondrial respiration and oxygen consumption (Schulz et al., 2007). This 
suggests that enhanced substrate flux and oxidation of calories is important in 
life span extension mediated by CR (Yuan et al., 2012). However, further 
analysis of mitochondrial function is necessary in order to better understand 
the effects of CR on metabolism. 
CR mimetics involve drug interventions which can result in physiological 
and anti-aging effects similar to CR without reducing caloric intake (Ingram et 
al., 2006). Hence, a promising anti-aging drug lead will most likely target 
systems involved in nutrient sensing, regulation, and metabolism, and 
subsequently shift cells to a physiological state of repair and maintenance. A 
major limitation in anti-aging therapeutic development lies in the generation of 
novel and bioactive compound libraries for drug screening. Based on studies 
on model organisms, polyketides and alkaloids, such as resveratrol and 
berberine respectively, can direct effects on AMPK (Um et al., 2010; Park et 
al., 2012; Chow and Sato, 2013) and sirtuin (Lagouge et al., 2006; Gertz et al., 





properties (Gruber et al., 2007; Houtkooper et al., 2013; Zhao and 
Darzynkiewicz, 2014), bringing us a step closer to developing an elixir of life. 
 
1.4  Polyketides and their potential in the development of caloric 
restriction mimetics 
Considerable focus has been awarded to polyketide research since its 
initial discovery about a century ago (Collie, 1907). Polyketides are 
structurally and functionally diverse secondary metabolites produced by 
bacteria, fungi, and plants. Many of these bioactive natural products have 
significant medical or agricultural applications (Staunton and Weissman, 
2001), such as rapamycin (a macrolide immunosuppressant) (Calne et al., 
1989), lovastatin (used for the treatment of hypercholesterolemia) (Alberts et 
al., 1980), actinorhodin (an antibiotic) (Wright and Hopwood, 1976), and 
resveratrol (reported anti-aging properties in model organisms) (Houtkooper et 
al., 2013). This highlights the vital role polyketides or their derivatives can 
play in the development of novel therapeutics (Newman and Cragg, 2012) 
such as CR mimetics. Although chemical synthesis can be used to generate 
polyketide analogues (Tatsuta and Hosokawa, 2006), the chemical and 
structural complexity of polyketides and their derivatives render this means 
difficult. 
 
1.4.1  Synthesis of polyketides by type I, type II, and type III polyketide 
synthases 
Insights into the biosynthetic mechanisms of polyketides only achieved 





potential biosynthetic pathway analogous to that of fatty acids (Birch and 
Donovan, 1953). Further advancements in the polyketide field led to the 
consensus that polyketides are typically biosynthesized via successive 
decarboxylative condensations of coenzyme A (CoA)-derived units, into a 
complex polycyclic multi-carbon compound containing hydroxyl or keto 
groups (Dunn and Khosla, 2013). Recent studies in the engineering and 
structural characterization of polyketide synthases (PKSs) have facilitated the 
usage of target enzymes as biocatalysts to generate novel functionally 
optimized polyketides, which can serve as potential drug leads (Abe, 2012). 
 
In general, PKSs are grouped into three classes: type I, II, or III PKS 
(Figure 1.3) (Staunton and Weissman, 2001). Type I PKSs are big multi-
domain polypeptides which can function in either a modular or iterative 
manner, shuttling substrates between functional domains through acyl carrier 
proteins (ACPs). In modular type I PKSs, functional domains are grouped into 
several modules, with each module being responsible for a distinct 
decarboxylative condensation step and the associated polyketide backbone 
modification in polyketide biosynthesis (Staunton and Weissman, 2001; Shen, 
2003). Conversely for iterative type I PKSs, the functional domains are 
clustered in only one module; hence, each domain is used repeatedly during 
each step of polyketide synthesis (Cox, 2007). Type II PKSs are dissociable 
multi-enzyme complexes, with each protein in the complex bearing an 
independent catalytic domain that is used iteratively during polyketide 
formation (Shen, 2003). Type III PKSs are homodimeric enzymes, which are 





The relative simplicity, versatility, and unusually broad substrate specificity of 
type III PKSs make them ideal candidates for the engineering of biocatalysts, 
enabling the access of bioactive polyketide compound libraries which can be 















Figure 1.3: Domain organization of the different PKSs. Putative domains are 
depicted by circles. In modular type I PKSs, functional domains are organized 
into modules, with each module being responsible for a single decarboxylative 
condensation step in polyketide formation. For iterative type I PKSs, the 
functional domains are clustered in a single module, and each domain is used 
repeatedly during polyketide biosynthesis. Type II PKSs are dissociable multi-
enzyme complexes, with each protein bearing one independent catalytic 
domain that is used iteratively. Type III PKSs are also iterative but do not 
require ACP to attach to the growing polyketide chain.  AT: Acyltransferase; 
ACP: Acyl carrier protein; KS: Ketosynthase; KR: Ketoreductase; DH: 
Dehydratase; ER: Enoyl reductase; TE: Thioesterase; CoA: Coenzyme A. 
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1.4.2  Chalcone synthase superfamily of type III polyketide synthases 
Unlike type I and II PKSs, type III PKSs generally employ CoA thioesters 
as substrates and do not entail the use of ACP domains. In addition, type III 
PKSs are capable of accomplishing an entire series of decarboxylative 
condensations and cyclization reactions in only a single active site (Staunton 
and Weissman, 2001). Its simple architecture enables type III PKSs to be 
amenable to in vitro manipulation and examination. Moreover, the inherent 
substrate promiscuity of these PKSs also permits them to accept unnatural 
precursors, thus generating an extensive range of compounds with novel 
scaffolds (Katsuyama et al., 2007; Go et al., 2015). Even though type III PKSs 
have been studied since the 1980s (Schuz et al., 1983), structural information 
on how a single active site can direct the chemistry of several decarboxylative 
condensations and subsequent cyclization of the polyketide was only made 
known after the crystal structure of chalcone synthase (CHS) from Medicago 
sativa (alfalfa) was solved (Ferrer et al., 1999). This was the first crystal 
structure of a PKS and it facilitated a framework for engineering type III PKSs 
to create novel polyketides. 
CHSs are the most well studied type III PKSs as they are ubiquitous in 
higher plants and crucial for plant metabolism and defense (Stewart et al., 
2013). Based on the structure of CHS from alfalfa, it was found that the 
symmetric dimer encapsulates a CoA-binding tunnel, a coumaroyl-binding 
pocket, and a cyclization pocket so as to facilitate chalcone biosynthesis 
(Ferrer et al., 1999). Together with the conserved Cys164-His303-Asn336 
catalytic triad, and the ‘gatekeeper’ Phe215 which is hypothesized to assist in 





connected cavities make up the active site architecture of a typical type III 
PKS (Figure 1.4) (Jez et al., 2000; Austin and Noel, 2003). Chalcone synthesis 
by CHS is initiated by the loading of p-coumaroyl-CoA onto the sulfhydryl 
group of the active site cysteine residue. The reaction then continues with 
three iterative decarboxylative condensations of the extender substrate, 
malonyl-CoA, with the cysteine-bound starter substrate, aided by the active 
site asparagine and histidine residues. After chain extension, the linear 
tetraketide, p-coumaroyl triacetyl thioester, undergoes an intramolecular C6 to 
C1 Claisen condensation and cyclizes into chalcone, which undergoes a 
further Michael-type ring closure to yield naringenin (Figure 1.5) (Austin and 
Noel, 2003). 
 
Figure 1.4: Crystal structure of a monomer of a modified CHS from alfalfa 
(PDB ID: 1U0W) showing the conserved Cys164-His303-Asn336 catalytic 
triad highlighted in red, and the ‘gatekeeper’ Phe215. A resveratrol molecule 
is co-crystallized in the active site cavity, and active site residues within 5 Å 







Numerous type III PKSs have been identified till date, and the variety of 
reactions and product classes discovered is due to differences in 
intramolecular cyclizations of the linear polyketide intermediate, the choice of 
starter and extender CoAs used, and the number of polyketide extension steps 
involved (Austin et al., 2004). The diverse polyketide scaffolds catalyzed by 
type III PKSs can be classified into different groups, such as chalcone, 
stilbene, pyrone, stilbenecarboxylate, curcuminoid, acridone, quinolone, 
phloroglucinol, resorcinol, and naphthalene families, amongst many others 
that were discovered (Austin and Noel, 2003; Abe and Morita, 2010). By 
characterizing type III PKSs, we can understand reaction mechanisms better 
and thus, direct the generation of unnatural polyketide compound libraries 





















Figure 1.5: Chalcone and naringenin synthesis catalyzed by M. sativa CHS 
using p-coumaroyl-CoA as the starter with malonyl-CoA as the extender. 
Truncation products of CHS undergo a spontaneous C5-oxygen to C1 
lactonization to form bisnoryangonin or p-coumaroyl triacetic acid lactone 
(CTAL). Another type III PKS, stilbene synthase (STS), can instead catalyze a 
C2 to C7 aldol condensation, followed by decarboxylation to yield the anti-
aging compound, resveratrol.  
 
1.4.3  Stilbene synthase superfamily of type III polyketide synthases 
Stilbene synthases (STSs) are identified in only a small subset of unrelated 
plants, unlike CHSs which are ubiquitous. STSs and CHSs are structurally 
related and share approximately 65% amino acid sequence identity 





mechanism which encompasses initiation, followed by the iterative 
decarboxylative condensation of three units of malonyl-CoA to a starter 
substrate, and lastly cyclization of the linear tetraketide intermediate. Slight 
variations in active site residues facilitate STSs to catalyze an intramolecular 
C2 to C7 aldol condensation, followed by decarboxylation and dehydration to 
create a stilbene scaffold instead of a chalcone backbone (Figure 1.5) (Austin 
et al., 2004). Previous homology modeling studies have revealed no 
substantial structural or chemical differences in the STS active site compared 
to CHS, and no obvious STS or CHS consensus sequence was recognized 
(Tropf et al., 1994; Austin et al., 2004). With the report of the first STS crystal 
structure from Pinus sylvestris (Scots pine) in 2004, the mechanism of stilbene 
biosynthesis was finally resolved (Austin et al., 2004; Abe and Morita, 2010). 
Structure-based mutagenic transformation of alfalfa CHS into STS showed 
that the different cyclization specificity of STSs is due to a conformational 
backbone change in a short, concealed loop between residues 132 and 137 in 
alfalfa CHS, that spans the dimer interface in the active site. Several amino 
acid substitutions at buried sites near this loop can lead to a slight 
displacement of Thr132, a residue that is conserved in both CHS and STS. 
Consequently, the side chain hydroxyl group of Thr132 is brought within the 
hydrogen bonding distance of a Ser338-stabilized water molecule adjacent to 
the catalytic cysteine, and a unique active site hydrogen bonding network 
comprising Glu192-Thr132-H2O-Ser338 forms in STS (Figure 1.6) (Austin 
and Noel, 2003; Austin et al., 2004; Shomura et al., 2005). The nucleophilic 
water activated by this “aldol-switch” hydrogen bonding network 





bound linear tetraketide intermediate. With the absence of the ester bond at 
C1, the intermediate is capable of undergoing a C2 to C7 aldol condensation 
and ultimately produces a stilbene scaffold. Hence in the case of CHS and 











Figure 1.6: The hydrogen bonding network involving Glu192, Thr132, H2O 
and Ser338 (numbering in alfalfa CHS). Differences in this network switches 
the chemistry of the active site of alfalfa CHS or Scots pine STS between 
chalcone and stilbene biosynthesis. 
 
Resveratrol is a polyphenolic phytoalexin that is commonly found in 
grapes, pine, nuts and dark chocolate. It is biosynthesized by STSs from p-
coumaroyl-CoA and malonyl-CoA. Resveratrol is hypothesized to be a CR 
mimetic (Chung et al., 2012; Gertz et al., 2012) as it increases mitochondrial 
resistance to oxidative stress and extends the life span of C. elegans (Gruber et 
al., 2007). It has also been found to extend the life span of other model 
organisms such as yeast and fruit flies (Bass et al., 2007). Resveratrol was 





expression and activity, bringing about mitochondrial biogenesis and cell 
survival (Menzies and Hood, 2012), thus mimicking CR and contributing to 
life span extension. Although resveratrol has some potential health benefits, its 
application on humans has limitations. One main problem of administering 
resveratrol in humans is its low solubility and high metabolism, resulting in 
low bioavailability (Pirola and Frojdo, 2008). A study in human subjects 
revealed that even after high oral doses, the peak amount of free resveratrol in 
the plasma only reached less than 2% of the total resveratrol administered, 
possibly explaining why resveratrol studies in humans have inconclusive 
results (Goldberg et al., 2003). In addition, some research has suggested that 
resveratrol may have potential side effects like nephrotoxicity (Crowell et al., 
2004; Cottart et al., 2010; Chung et al., 2012). Consequently, there is a need to 
discover new CR mimetics that are more potent than resveratrol in bringing 
about life span extension in humans. It will be useful if we can utilize enzymes 
like resveratrol synthase to conduct precursor-directed biosynthesis of novel 
polyketides which still retain the phenol moieties for potential biological 
activities. 
 
1.4.4  Precursor-directed combinatorial biosynthesis of unnatural 
polyketides 
Considerable effort has been spent in exploring the biosynthesis of 
polyketides, and although there has been good progress, rationally guided 
combinatorial biosynthesis to produce novel and bioactive polyketides remains 
difficult. Using in vitro assays, when both the starters and the extenders were 





baicalensis was able to catalyze the production of unnatural polyketides (Abe 
et al., 2003). Other than the preferred substrates of p-coumaroyl-CoA and 
malonyl-CoA, S. baicalensis CHS was able to accept benzoyl-CoA as a starter 
and methylmalonyl-CoA as the extender to produce methylated triketide and 
tetraketide pyrones. Similar to studies on CHSs, STS from Arachis hypogaea 
(peanut) was also found to accept several unnatural substrates to produce 
unique stilbene-like products (Morita et al., 2001).  
Synthetic enzymology is the use of enzymological principles such as 
combinatorial biosynthesis, mechanistic enzymology, and enzyme engineering 
in the intentional design of biological systems for purposeful function (Go et 
al., 2015). Although synthetic biology and the idea to engineer organisms 
were first posited in the 1960s, the synthetic biology field only picked up 
momentum after the year 2000 when technological advancements such as 
improved computational programs and automated DNA sequencing surfaced 
(Cameron et al., 2014).  By manipulating a number of promiscuous acid-CoA 
ligases and PKSs together in a microbial host like Escherichia coli 
(Katsuyama et al., 2007; Go et al., 2012; Go et al., 2015), novel acyl-CoA 
precursors can be delivered to PKSs, thus generating a large library of novel 
polyketides with therapeutic potential via precursor-directed combinatorial 
biosynthesis (Figure 1.7A).  
A starter acid such as p-coumaric acid can be converted to p-coumaroyl-
CoA via a CoA ligase, while malonic acid can be converted to the extender 
CoA, malonyl-CoA, by a malonyl-CoA synthetase (MCS). A type III PKS 
such as resveratrol synthase is then capable of using one unit of starter-CoA 





(Figure 1.7B). Since the CoA ligases and PKS used are promiscuous in 
activity, different precursors can be used to direct the biosynthesis of 
polyketide compound libraries, which can be otherwise difficult to obtain for 
screening assays. Positions of critical pharmacophoric moieties in polyketides 
can be manipulated easily by varying the carboxylic acid used in the 
biosynthesis. Additional diversity also comes from the number of elongation 
steps in polyketide biosynthesis, and the cyclization mechanisms of the 
intermediate (Austin et al., 2004). In contrast, modifications done using 
chemical synthesis are more challenging due to the generation of side products 
and low yields (Tatsuta and Hosokawa, 2006). Furthermore, precursor-
directed combinatorial biosynthesis is believed to be capable of creating 
compound libraries with sufficient diversity and complexity that is not 
attainable by chemical synthesis (Katsuyama et al., 2007; Chemler and 
Koffas, 2008). It is interesting to note that due to a lack of a toolkit to modify 
drug compounds easily, the chemically synthesized derivatives of resveratrol 
are currently limited to simple functional group changes in the aromatic rings, 
such as fluoro, amino, hydroxyl, methyl, methoxy, acetyl, and methyl ester 
derivatives which are usually produced via the Wittig reaction or Heck 




















Figure 1.7: Precursor-directed combinatorial biosynthesis of novel 
polyketides. (A) Promiscuous substrate specificities of choice CoA ligases can 
deliver unnatural acyl-CoA esters to PKSs, which can in turn generate novel 
polyketide compound libraries. (B) In one of the combinatorial biosynthetic 
pathways, resveratrol synthase utilizes one unit of p-coumaroyl-CoA and three 
units of malonyl-CoA, generated by a CoA ligase and malonyl-CoA 
synthetase respectively, to yield the polyketide resveratrol. 
 
 
1.5  Alkaloids as potential caloric restriction mimetics 
Compared to polyketides and other classes of low molecular weight 
natural compounds, alkaloids have the highest structural diversity (Cordell et 
al., 2001). Alkaloids contain the basic nitrogen in addition to carbon and 
hydrogen, and some may contain oxygen, sulphur, and other elements. They 
are initially isolated mainly from plants but are now found to be widely 
distributed in animal (Daly et al., 1987; Laurent et al., 2003) and microbial 
(Liu et al., 2015; Young et al., 2015) species too.  
Like polyketides, alkaloids play an important role in the pharmaceutical 
industry. The first alkaloid was discovered in 1817 by Sertürner from Papaver 
somniferum (opium poppy) and is known commonly as the analgesic drug, 





constituent in Coptis chinensis Franch extracts, a herb used to treat 
gastrointestinal disorders and diabetes in traditional Chinese medicine for 
more than 2000 years (Ko et al., 2005; Wang et al., 2014). Interestingly, 
berberine is now known to have potential anti-aging properties in fruit flies 
(Navrotskaya et al., 2012). At least 21,120 alkaloids have been discovered, but 
only 3.3% of these were evaluated in no more than five bioassays (Cordell et 
al., 2001). Hence, the untapped potential of alkaloids as therapeutic drug leads 
is profound. 
 
1.5.1  Biosynthesis of alkaloids in nature 
Alkaloids are extremely diverse and can be classified based on their 
biosynthetic pathways and chemical structures. Depending on the precursors 
used, and the final structure of the alkaloids, the assorted alkaloid scaffolds 
can be grouped into different classes such as simple amines, oxazoles, 
isoquinolines, quinolines, indoles, imidazoles, pyrrolidines, pyrrolizidines, 
tropanes, polyamines, piperidines, quinolizidines, indolizidines, quinazolines, 
pyridines, and aminated purines and terpenes (Figure 1.8) (Cordell et al., 
2001). The biosynthetic pathway of alkaloids in nature branched out from 
main metabolic pathways to secondary pathways to yield the different 
precursors and intermediates of alkaloids. Alkaloids can be derived from L-
amino acids such as L-tryptophan, L-phenylalanine, L-tyrosine, L-histidine, L-
ornithine, and L-lysine. Other building blocks of alkaloids include anthranilic 
acid, nicotinic acid, purines, acetate, selected polyterpene units, and polyketide 
units (Cordell et al., 2001; Cordell, 2013). From a single L-amino acid, step-





alkaloid scaffolds. For instance, L-tryptophan can be converted to indole 
alkaloids, terpenoid indole alkaloids such as the ergot alkaloids in several 
fungal species, and quinoline alkaloids. A classic example of an ergot alkaloid 
is lysergic acid (Young et al., 2015). Given the diversity of bioactive 
alkaloids, they have a huge potential in therapeutic drug development (Figure 
1.8) (Meneses, 1998; Kobayashi et al., 1999; Cordell et al., 2001; 
Wattanathorn et al., 2008; Karmase et al., 2013; Servillo et al., 2013; 











































Figure 1.8: Diverse alkaloid scaffolds and their precursors. Some alkaloids are 





1.5.2  Precursor-directed combinatorial biosynthesis as a novel means to 
produce alkaloids 
Alkaloids can be obtained through several methods such as extraction from 
the source directly, chemical synthesis, and biosynthesis via enzymes. 
Extraction from the source is difficult and not economically feasible because 
alkaloids are typically only present in low amounts of 1% to 2% of dried 
biomass (Cordell et al., 2001). This is due to the fact that alkaloids are 
secondary metabolites in many organisms, and are generally not essential for 
the survival of the plants. Chemical synthesis is also challenging and not cost-
effective because the extremely diverse structures of alkaloids will pose 
difficulties in the production of complex alkaloids from simple chemical 
substrates (Minami et al., 2008). Enzymes on the other hand are optimized for 
the generation of bioactive compounds, therefore biosynthesis should have 
better yields of desired target compounds. However, conventional biochemical 
pathways of synthesizing alkaloids in plants can be lengthy, 
compartmentalized and localized to different cell types, and tightly regulated, 
making them difficult to manipulate using molecular biology (Facchini, 2001; 
Ziegler and Facchini, 2008). By establishing a precursor-directed 
combinatorial biosynthetic route involving promiscuous acid-CoA ligases and 
PKSs, and utilizing nitrogen-containing compounds as substrates, a wide 
range of alkaloids can be biosynthesized (Figure 1.9).  
Similar to the precursor-directed combinatorial biosynthesis of polyketide 
libraries, promiscuous acid-CoA ligases are able to biosynthesize unique 
nitrogen-containing acyl-CoA esters which can act as the starter and/or 





the choice of starter and extender CoA esters used. Furthermore, the number 
of elongation steps catalyzed, and the mode of cyclization of the 
intermediates, provide a further element of structural diversity (Austin et al., 
2004). By manipulating PKSs innovatively, this represents a novel and 







Figure 1.9: Precursor-directed combinatorial biosynthesis of novel alkaloids. 
Promiscuous substrate specificities of choice CoA ligases can deliver 
nitrogen-containing acyl-CoA esters to PKSs, which can in turn generate 
alkaloid compound libraries. These unnatural alkaloids can then be introduced 
to model organisms like C. elegans to test for anti-aging properties.  
 
 
1.6  Anti-aging therapeutic development 
With a bioactive library of polyketides and alkaloids, anti-aging 
therapeutics can be developed. The conventional way of anti-aging drug 
screening is via life span assays. However even for the relatively short-lived 
model organism C. elegans, life span assays are time consuming and 
impractical to screen for a large library of bioactive compounds. This study 
aims to develop a medium throughput screening methodology by conducting 
mitochondrial function assays on C. elegans exposed to various drugs using an 
Extracellular Flux Analyzer. By periodically introducing pharmacological 
agents such as electron transport chain (ETC) inhibitors to manipulate 





C. elegans can be looked into, so as to establish a connection between oxygen 
consumption rates (OCR), CR mimetics, and life span extension.  
Preliminary studies showed that worms subjected to CR had a higher 
metabolic rate and thus a higher OCR and better mitochondrial function than 
worms fed on a normal diet (Schulz et al., 2007; Yuan et al., 2012). 
Consequently, treatment with CR mimetics is likely to have a similar effect on 
C. elegans as reductions in caloric intake. Since resveratrol is a potential CR 
mimetic, the mitochondrial respiration profile of resveratrol-treated C. elegans 
can be analyzed, which will function as a reference for future screening of 
potential CR mimetics to narrow down drug hits for subsequent validation 
studies.  
Different dietary interventions and therapeutic drug leads have been 
studied for their potential to counter age-associated dysfunctions. By looking 
for polyketides and alkaloids that can alleviate declines in mitochondrial 
function and aerobic capacity, which is one of the hallmarks of aging, it is 
believed that the aging process can be modulated. This study serves as a 
primer towards the development of unique anti-aging neutraceuticals via 






CHAPTER 2: TOWARDS THE DEVELOPMENT OF NOVEL ANTI-
AGING POLYKETIDES USING PRECURSOR-DIRECTED 
COMBINATORIAL BIOSYNTHESIS 
 
2.1  Introduction 
Several studies have illustrated the feasibility of performing precursor-
directed combinatorial biosynthesis using type III PKSs to generate novel 
polyketides (Katsuyama et al., 2007; Abe and Morita, 2010). Recently, a 
group of researchers demonstrated the production of novel polyketides via 
precursor-directed combinatorial biosynthesis and identified some lead 
compounds with anti-angiogenic or anti-cancer properties (Kim et al., 2009; 
Kwon et al., 2010). Similar work in synthetic enzymology using a CHS from 
Oryza sativa (rice) led to the development of novel polyketides as 
antimicrobial drug leads (Go et al., 2015).  
Previous substrate specificity studies have demonstrated the production of 
unnatural polyketides by the promiscuous alfalfa CHS. Alfalfa CHS was 
reported to utilize 3-phenylpropanoyl, phenylacetyl, benzoyl, several 
derivatives of cinnamyl, and short to medium-length aliphatic acyl-CoA 
thioesters to biosynthesize a range of compounds including chalcones and 
lactones (Jez et al., 2002). These studies were limited mostly to structural 
derivatives of the cognate substrates from the cinnamyl-CoA and malonyl-
CoA families, due to a lack of a means to deliver novel acyl-CoA precursors.  
Mutagenesis studies on alfalfa CHS led to the development of a mutant 
CHS with STS activity (CHS18) (Austin et al., 2004). Eighteen distal amino 





resulting in a new active site hydrogen bonding network comprising Glu192-
Thr132-H2O-Ser338, which caused the PKS (CHS18) to produce resveratrol 
as the major product and naringenin as the minor product when incubated with 
p-coumaroyl-CoA and malonyl-CoA. An exploration of the substrate 
specificity of CHS18 across various acyl-CoA classes has not been 
systematically attempted or reported. Since CHS18 is able to produce the CR 
mimetic resveratrol, and it originated from the promiscuous alfalfa CHS 
scaffold (Jez et al., 2002), it provided an excellent platform for the engineered 
biosynthesis of novel bioactive stilbenes and other polyketides with potential 
anti-aging activities. In precursor-directed combinatorial biosynthesis, 
production of unnatural acyl-CoA esters by promiscuous CoA-ligases was 
coupled to polyketide biosynthesis by CHS18. The whole combinatorial 
biosynthetic pathway was constructed in E. coli so as to make use of its own 
ATP and CoA for the biosynthesis of our desired products. By establishing the 
substrate and product profiles of CHS18, we can direct the biosynthesis of 








2.2  Materials and methods 
The carboxylic acid substrates for acid-CoA ligases were obtained from 
Sigma-Aldrich Co. (St. Louis, MO, USA), Tokyo Chemical Industry Co. 
(Tokyo, Japan), Extrasynthese Co. (Genay Cedex, France), and Lier Chemical 
Co. (Sichuan, People’s Republic of China). A total of 81 carboxylic acids 
were utilized as precursors for acyl-CoA thioester biosynthesis catalyzed by 
four acid-CoA ligases (Go et al., 2012). The acids were from the malonate, 
cinnamate, phenylpropanoate, benzoate, phenylacetate, naphthalene, 
quinoline, saturated aliphatic, and unsaturated aliphatic families. All reagents 
were of the best quality grade that is available commercially. 
  A total of 12 malonate-type acids form the extender substrates for 
precursor-directed combinatorial biosynthesis and include: malonic acid, 
methylmalonic acid, ethylmalonic acid, isopropylmalonic acid, butylmalonic 
acid, allylmalonic acid, hydroxymalonic acid, fluoromalonic acid, 
chloromalonic acid, bromomalonic acid, phenylmalonic acid, and 3-
thiophenemalonic acid.  The remaining 69 carboxylic acids form the starter 
substrates and include: (cinnamate type) cinnamic acid, 2-fluorocinnamic 
acid, 3-fluorocinnamic acid, 4-fluorocinnamic acid, α-fluorocinnamic acid, 3-
chlorocinnamic acid, 3-chloro-4-methoxycinnamic acid, 4-chlorocinnamic 
acid, 2-hydroxycinnamic acid, 4-hydroxycinnamic acid (also known as p-
coumaric acid), 3-methoxy-4-hydroxycinnamic acid, 4-methoxycinnamic acid, 
4-methylcinnamic acid, α-methylcinnamic acid; (phenylpropanoate type) 3-
phenylpropanoic acid, 3-(3′-chloro)phenylpropanoic acid, 3-(3′-chloro-4′-
methoxy)phenylpropanoic acid, 3-(3’,4’-dihydroxy)phenylpropanoic acid, 3-





(4′-fluoro)phenylpropanoic acid; (benzoate type) benzoic acid, 2-
fluorobenzoic acid, 3-fluorobenzoic acid, 4-fluorobenzoic acid, 2,6-
difluorobenzoic acid, 2-chlorobenzoic acid, 3-chlorobenzoic acid, 4- 
chlorobenzoic acid, 2-bromobenzoic acid, 3-bromobenzoic acid, 4-
bromobenzoic acid, 2-iodobenzoic acid, 2-hydroxybenzoic acid, 2,3-
dihydroxybenzoic acid, 2,4-dihydroxybenzoic acid, 2,5-dihydroxybenzoic 
acid, 2-methoxybenzoic acid, 2-methylbenzoic acid, 3-aminobenzoic acid, 4-
aminobenzoic acid; (phenylacetate type) phenylacetic acid, 2-
hydroxyphenylacetic acid, 4-hydroxyphenylacetic acid, 4-
methoxyphenylacetic acid, phenoxyacetic acid, phenylpyruvic acid; 
(naphthalene and quinoline type) 1-naphthalenecarboxylic acid, 2-
naphthalenecarboxylic acid, 2-quinolinecarboxylic acid, 3-quinolinecarboxylic 
acid; (saturated aliphatic type) propanoic acid, butanoic acid, pentanoic acid, 
hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, decanoic acid; 
(unsaturated aliphatic type) 2-butenoic acid, 2-methyl-2-butenoic acid, 3-
methyl-2-butenoic acid, 3-butenoic acid, 2-pentenoic acid, 3-pentenoic acid, 4-
pentenoic acid, 3-methyl-4-pentenoic acid, 3-hexenoic acid, 5-hexenoic acid. 
The chemical structures of all substrates tested are depicted in Table A1 in the 
Appendix.  
 
2.2.1  Establishing a combinatorial biosynthetic route in Escherichia coli 
The type III PKS used in this research study is a mutant CHS with STS 
activity from M. sativa that was previously created by Austin et al. in 2004. 
Alfalfa CHS (GI: 166363) was cloned previously in the lab from M. sativa 





ten histidine tags at the N-terminus of the protein. PCR-mediated mutagenesis 
was conducted with reference to the paper published by Austin et al. (2004) in 
order to replicate the same mutations in alfalfa CHS, resulting in CHS18 
which has STS activity. In particular, the amino acids Asp98, Val100, Val101, 
Val102, Thr131, Ser133, Gly134, Val135, Met137, Tyr158, Met159, Met160, 
Tyr161, Gln163, Leu268, Lys269, Asp270, and Gly273 in alfalfa CHS were 
mutated to Ala98, Leu100, Ala101, Met102, Ser131, Thr133, Thr134, Pro135, 
Leu137, Val158, Gly159, Val160, Phe161, His163, Lys268, Gly269, Ala270, 
and Asp273 in CHS18. 
MCS (GI: 3982573) and phenylacetate-CoA ligase (PCL) (GI: 1099823) 
were cloned previously in the laboratory from Rhizobium trifolii genomic 
DNA (ATCC) and Streptomyces coelicolor A3(2) genomic DNA (ATCC) 
respectively, each into a Tom-15b vector containing 10 histidine tags at the N-
terminus of the protein. Benzoate-CoA ligase (BZL) (GI: 1040685) from 
Rhodopseudomonas palustri and 4-coumarate-CoA ligase (4CL) (GI: 
12229632) from Nicotiana tabacum were kindly provided by E. Pichershky 
(Beuerle and Pichersky, 2002) in a pCRT7/CT-TOPO vector (Invitrogen) 
containing six histidine tags at the C-terminus of the protein. 
In order to establish a combinatorial biosynthetic route in E. coli, three 
CoA ligases (4CL, PCL and BZL) that are involved in the generation of starter 
CoA thioesters were subcloned into the multiple cloning site 1 (MCS1) of a 
pRSFDuet-1 vector (Novagen) separately. To produce the extender CoA 
thioesters, MCS and PCL were each subcloned into the MCS2 region of the 
same vector. Thereafter, this pRSFDuet-1 vector was co-transformed with the 





(Novagen) (Figure 2.1). Depending on the identity of the starter and extender 
acids, E. coli harboring the appropriate combination of CoA ligases was used 
for the in vivo precursor-directed combinatorial biosynthesis of polyketides 
(see Table A1 in Appendix). An E. coli construct without the CHS18 gene was 
also prepared to serve as a control for the subsequent detection of novel 
polyketides. A matrix of 69 starter acids with 12 extender acids were 
separately introduced to the engineered E. coli host cells, giving a possible 
combination of 828 substrate profiles. 
 
 
Figure 2.1: E. coli constructs generated for in vivo precursor-directed 
combinatorial biosynthesis of polyketides. Constructs containing the CoA 
ligases with an empty Tom-15b vector served as controls during the 
subsequent high performance liquid chromatography (HPLC) analyses. 
 
2.2.2 In vivo precursor-directed combinatorial biosynthesis of 
polyketides and HPLC analysis 
The E. coli host cells harboring the biosynthetic genes were first grown in 
10 mL Lysogeny Broth (LB) containing 34 µg/mL chloramphenicol, 100 
µg/mL ampicillin, and 30 µg/mL kanamycin at 25°C. When OD600nm reached 





thiogalactopyranoside (IPTG) for 16 h. The cells were subsequently pelleted 
and resuspended in 10 mL minimal medium containing antibiotics, 0.1 mM 
IPTG, 1 mM starter acid and 1 mM extender acid, and incubated at 25°C for a 
further 72 h. The carboxylic acids were introduced only after the enzymes had 
been expressed, so that any potential toxicities to the E. coli due to the acids, 
CoA esters, or polyketides formed will have minimal effects on the expression 
of the enzymes and yields of the products. In addition, the carboxylic acids 
were introduced at 1 mM so as to ensure the maintenance of the highest 
possible intracellular concentration of carboxylic acids over 72 h without 
killing the cells, given that the uptake rates for the starter and extender acids 
into E. coli could have some slight variations. After centrifugation, the 
supernatant was acidified to pH 3.0 with 6 M HCl and extracted with ethyl 
acetate thrice. The organic solvent was subsequently removed by a vacuum 
concentrator, and the residue was dissolved in 100 µL dimethyl sulfoxide 
(DMSO) for HPLC analysis. 
The Atlantis Analytical C18 reverse-phase column (Waters) was first 
equilibrated with 10% acetonitrile, 0.1% trifluoroacetic acid (TFA) in water at 
a flow rate of 1 mL/min for 15 min. 10 µL of sample was then loaded onto the 
column and the mobile phase was changed to 50% acetonitrile, 0.1% TFA in 
water under a linear gradient over a period of 40 min at a flow rate of 1 
mL/min. For the next 5 min, a linear gradient to 100% acetonitrile containing 
0.1% TFA was conducted. The eluted compounds were detected by measuring 
the absorbance at 230 nm, 280 nm, 320 nm, and 370 nm. Chromatogram peaks 





constructs containing CHS18 but absent in the extracts of control constructs, 
indicate the occurrence of polyketide biosynthesis.  
 
2.2.3 Expression and purification of CoA ligases and CHS18 
Tom-15b plasmids harboring the genes encoding MCS, PCL, or CHS18, 
and pCRT7/CT-TOPO vector harboring the gene encoding BZL were 
transformed individually into E. coli BL21(DE3) strain for expression. The 
pCRT7/CT-TOPO plasmid harboring the gene encoding 4CL was transformed 
into E. coli Rosetta II (DE3) strain for expression. The transformed host cells 
were grown in LB at 25C, supplemented with either 100 g/mL ampicillin 
(for BL21 (DE3) strains) or 34 g/mL chloramphenicol and 100 g/mL 
ampicillin (for Rosetta II (DE3) strain). When OD600nm reached 0.6, protein 
expression was induced by 0.1 mM IPTG for 16 h. The cells were 
subsequently harvested by centrifugation and stored at -20C. 
To purify these enzymes, the cell pellets were resuspended in a binding 
buffer containing 20 mM Tris-HCl (pH 7.9), 500 mM NaCl, and 5 mM 
imidazole. The cells were subsequently lysed by sonication, and the cell lysate 
was centrifuged at 21,000 rpm for 20 min. The supernatant containing His-
tagged proteins was passed through a column of chelating Sepharose resin 
(GE Healthcare Bio-Sciences Corp) charged with Ni2+. The column was 
washed with five column volumes (CV) of binding buffer, followed by five 
CV of wash buffer containing 20 mM Tris-HCl (pH 7.9), 500 mM NaCl, and 
107 mM imidazole. After that, the enzymes were eluted with buffer containing 
20 mM Tris-HCl (pH 7.9), 500 mM NaCl, and 100 mM L-histidine. Fractions 





a storage buffer containing 20 mM Tris-HCl (pH 7.9) and 100 mM NaCl. The 
solutions containing the purified enzymes were concentrated to around 10 – 30 
mg/mL using 10 kDa Amicon Ultra centrifugal filter units (Millipore), and 
stored in aliquots at -80C. 
 
2.2.4 In vitro precursor-directed combinatorial biosynthesis of 
polyketides and HPLC analysis 
In order to obtain a higher yield of polyketides for subsequent mass 
spectrometry (MS) and nuclear magnetic resonance (NMR) analyses, in vitro 
precursor-directed combinatorial biosynthesis of polyketides was conducted. 
Initial biosyntheses of the starter and extender CoA thioesters were carried out 
in 1 mL reaction mixtures containing 100 mM Tris-HCL (pH 8.0), 10 mM 
MgCl2, 10 mM 5’-Adenosine Triphosphate (ATP), 0.5 mM CoA, 2.5 mM 
starter acid, 5 mM extender acid, 2 mg/mL 4CL / PCL / BZL, and 2 mg/mL 
MCS or PCL. After incubation for 6 h at 25°C, additional cofactors, CoA 
ligases, and 2 mg/mL CHS18 were added to give a final reaction volume of 2 
mL, containing 100 mM Tris (pH 8.0), 10 mM MgCl2, <10 mM ATP, <0.5 
mM CoA, <2.5 mM starter acid, <5 mM extender acid, <0.5 mM starter CoA, 
<0.5 mM extender CoA, 2 mg/mL 4CL / PCL / BZL, 2 mg/mL MCS or PCL, 
and 2 mg/mL CHS18. This ensures that there are adequate amounts of ATP, 
CoA, and ligases for the reactions to be completed. Due to the presence of a 
CoA regeneration system involving CoA ligases and CHS18, only a low 
amount of the expensive CoA is needed for the biosynthesis of polyketides to 
take place. An aliquot of 400 µL of the reaction mixture was immediately 





membranes (Millipore) to remove all enzymes from the mixture. The filtrate 
(representing time = 0 h) was collected and stored at -80°C until HPLC 
analysis. The remaining 1.6 mL reaction mixture was then incubated at 25°C 
for another 20 h. Subsequently, enzymes were removed via centrifugation 
through Ultracel membranes, and the filtrate (representing time = 20 h) was 
collected and stored at -80°C until HPLC analysis. 
In order to purify the novel polyketide products from the reaction mixture, 
HPLC analysis was conducted as in section 2.2.2, with minimal changes. The 
Atlantis Prep C18 reverse-phase column (Waters) was used instead, and first 
equilibrated with 10% acetonitrile, 0.1% TFA in water at a flow rate of 5 
mL/min for 15 min. Up to 800 µL of sample was loaded and the column was 
washed with 10% acetonitrile, 0.1% TFA in water at a flow rate of 5 mL/min 
for 4 min. The novel polyketides were eluted with a linear gradient from 10% 
acetonitrile, 0.1% TFA in water to 50% acetonitrile, 0.1% TFA in water over a 
period of 40 min at a flow rate of 5 mL/min. For the next 5 min, a linear 
gradient to 100% acetonitrile containing 0.1% TFA was conducted. Eluted 
compounds were detected by measuring the absorbance at 230 nm, 280 nm, 
and 320 nm. Fractions that were only present in the 20 h time-point samples 
and absent in the 0 h time-point samples indicate polyketide biosynthesis, and 
were lyophilized, and sent for MS or NMR analyses. Purified resveratrol 
fractions were also used for life span assays in C. elegans. 
 
2.2.5  Mass spectrometry profiling of novel polyketides 
MS analysis was conducted under the assistance of our collaborator, Dr. 





Singapore. HPLC-MS/MS analysis of the purified polyketides was carried out 
on a QTOF 6550 with iFunnel and turbo ion spray, connected to a UHPLC 
1290 (AGILENT, Singapore). The Phenomenex Synergy-Polar C18, 2.1 mm x 
50 mm column, with 3 µm particle size (Phenomenex, US) was first 
equilibrated with 5% acetonitrile, 0.2% formic acid in water for 1 min at a 
flow rate of 600 µL/min. The samples were dissolved in 100 µL acetonitrile, 
and 2 µL was loaded for the analysis. Separation of the polyketides was 
performed with a gradient from 5% acetonitrile, 0.2% formic acid in water to 
90% acetonitrile, 0.2% formic acid in water over 5 min. 90% acetonitrile, 
0.2% formic acid in water was then maintained for another 1 min, with the 
column temperature set at 40˚C throughout the run. The mass spectrometer 
was set to a MS scan range from 100 to 1400 m/z at 1 scan/sec, and the three 
most intense precursor ions were selected for fragmentation at a fixed collision 
energy of 35. Electrospray conditions were optimized for the polyketides in 
previous experiments in their laboratory. Data were recorded with Masshunter 
Acquisition B6.0 (AGILENT) and analyzed with Masshunter Qualitative 
Analysis software version 6 (AGILENT). After MS detection, NMR analyses 
of selected compounds were carried out by the Nuclear Magnetic Resonance 
Laboratory (Department of Chemistry, National University of Singapore). 
 
2.2.6 Life span assays using resveratrol or novel polyketides 
C. elegans were maintained as in Stiernagle (2006) with slight changes. 
Various concentrations (5 μM, 20 μM, 40 μM, or 50 μM) of resveratrol (TCI 
Co.) or DMSO (as a control) were incorporated into 5 cm nematode growth 





assays. NGM plates used for life span assays also contained 90 μM 5-fluoro-
2’-deoxyuridine (FUdR) (Sigma-Aldrich Co.) which is an inhibitor of 
thymidylate synthase. Hence, DNA synthesis is inhibited and this prevents cell 
division, growth, and hatching of young C. elegans which can complicate 
results analyses (Mitchell et al., 1979). Adult worms on the other hand, are not 
affected by FUdR treatment as all adults do not undergo any further cell 
division after reaching the 959-cell stage. Cultures of E. coli OP50 strain 
(obtained from Dr. Takao Inoue, Department of Biochemistry, National 
University of Singapore) were grown in LB overnight at 25°C, and 
concentrated 10-fold by centrifugation and resuspension in a smaller volume 
of LB. OP50 was then spotted onto these NGM agar plates as the food source 
for C. elegans, and allowed to dry overnight at room temperature. Wild-type 
C. elegans N2 strain (obtained from Dr. Takao Inoue) were cultured at 20°C 
on the various NGM agar plates containing a lawn of E. coli OP50. 
Age-synchronized wild-type N2 worms were acquired by first placing 
adult worms on NGM agar plates without FUdR, and allowing them to lay 
eggs for 4 h. Hypochlorite treatment (Stiernagle, 2006) was utilized to kill and 
remove adult worms, and eggs were obtained by centrifugation. Eggs were 
washed thrice with autoclaved water, transferred onto NGM plates without 
FUdR, and allowed to hatch and grow to adults at 20°C. A total of 20 – 25 
age-synchronized adult N2 worms were transferred randomly to each 
treatment plate, to begin the life span assay (third day after hatching is 
equivalent to day one of adult life span at 20°C). Worms were transferred to a 
fresh treatment plate every day using a sterile platinum wire, for the first week 





progeny. Additional E. coli OP50 was supplemented to the treatment plates at 
day 12 as worms could be too old to be transferred manually. Worms were 
scored daily, and scored as dead if no response was observed when they were 
gently prodded with a platinum wire. C. elegans that were lost due to crawling 
on the walls of the agar plates were omitted from analysis. Survival analysis 
was conducted using the log rank test in the IBM SPSS Statistics 22 program. 
For life span assays using novel polyketides, selected combinations of 0.5 
mM starter acids and 1 mM extender acids together with 90 μM FUdR, 34 
µg/mL chloramphenicol, 100 µg/mL ampicillin, 30 µg/mL kanamycin, and 0.1 
mM IPTG were incorporated into NGM agar plates. The corresponding CoA 
ligases + CHS18 E. coli constructs, and constructs without CHS18 were 
grown in LB with antibiotics overnight at 25°C by another lab member to 
ensure blinding of the life span studies. Protein expression was induced by 0.1 
mM IPTG for 3 h at 25°C, and 0.5 mM starter acids and 1 mM extender acids 
were subsequently introduced to the media. After incubation at 25°C for 
another 3 h, the E. coli culture was concentrated 20-fold as above, seeded onto 
the respective NGM plates, and allowed to dry overnight at room temperature 
as the food source which can expose C. elegans to the biosynthesized novel 
polyketides concurrently. The life spans of wild-type N2 C. elegans exposed 
to the CoA thioesters and novel polyketides were compared to the life spans of 







2.3  Results and discussion 
2.3.1  Establishing a combinatorial biosynthetic route in Escherichia coli  
Since most starter and extender CoA thioesters are either too expensive to 
obtain, or not commercially available, the biosynthesis of CoA thioesters had 
to be coupled to the PKS, CHS18, in order to generate polyketides. This 
mutant chalcone synthase (CHS18) was cloned into E. coli, together with 4CL 
from N. tabacum and MCS from R. trifolii. A control E. coli construct 
containing 4CL, MCS, and an empty Tom-15b vector was also constructed. 
The CoA ligases had previously been shown to catalyze the biosynthesis of 
CoA thioesters from their respective carboxylic acid precursors (Go et al., 
2012). By supplying p-coumaric acid and malonic acid to the E. coli 
constructs, p-coumaroyl-CoA and malonyl-CoA were synthesized by 4CL and 
MCS respectively. CHS18 was validated to have resveratrol synthase activity 
when incubated with the biosynthesized p-coumaroyl-CoA and malonyl-CoA 
(Figure 2.2). The resveratrol generated by CHS18 was verified to have an 
experimental mass of 227.0712 in the negative MS mode (theoretical mass of 
228.25) (Figure 2.3), and NMR analysis further established the identity of the 
compound (Figure 2.4). Several minor HPLC peaks were also observed at Rt 
of 24.4 min, 33.8 min, 35.0 min, and 40.4 min, indicating the potential 
biosynthesis of bisnoryangonin, CTAL, naringenin, and other polyketides with 
a different number of extension step or an alternate intramolecular cyclization 
mode as minor products. This allowed us to set up the platform for precursor-
directed combinatorial biosynthesis, which requires the utilization of different 






Figure 2.2: Malonic acid and p-coumaric acid were supplemented to the E. 
coli constructs. Biosynthesized products in spent minimal medium containing 
either E. coli with CoA ligases + CHS18 or E. coli with CoA ligases only 
(control construct) were extracted and subjected to HPLC analysis using an 
Atlantis Analytical C18 reverse-phase column. An additional peak 
corresponding to resveratrol was observed in the extract from the CHS18 
construct, but was absent in the extract from the control construct. The 
retention time (Rt) of the additional peak was found to be identical to the Rt of 








Figure 2.3: MS analysis of purified resveratrol fraction after in vivo precursor-
directed combinatorial biosynthesis. The mass of the biosynthesized product 






Figure 2.4: Overlay of NMR analyses of purified resveratrol fraction after in 
vitro precursor-directed combinatorial biosynthesis (red), and a commercially 
available resveratrol standard (blue). Both spectra are quite similar to each 
other, although there may be a low level of contamination in the purified 
resveratrol fraction. 
 
Using precursor-directed biosynthesis via different combinations of 69 
starter CoA thioesters and 12 extender malonyl-CoA derivatives, the substrate 
profile of CHS18 was established (Table 2.1), and a catalog of polyketides 
was obtained. CHS18 was found to be promiscuous in substrate utilization, 
consistent with previously characterized alfalfa CHS (Jez et al., 2002). CHS18 
was able to utilize unnatural starter and extender CoA thioesters as substrates 
for polyketide synthesis (Figure 2.5 and Figures A1 to A5), thus highlighting 
the feasibility of precursor-directed combinatorial biosynthesis of polyketides. 
From the matrix of substrates used, at least 413 novel polyketides were 
generated. Differences in the production yield of the novel polyketides 






Table 2.1: Substrate profile of CHS18 using 69 starter CoA thioesters and 12 
extender CoA thioesters. 413 out of 828 possible combinations (49.9%) gave 
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Figure 2.5: Biosynthesized products in spent minimal medium containing 
either E. coli with CoA ligases + CHS18 or E. coli with CoA ligases only 
(control construct) were extracted and subjected to HPLC analysis using an 
Atlantis Analytical C18 reverse-phase column. An additional peak at Rt 38.7 
min was observed in the extract from the CHS18 construct, but was not 
present in the extract from the control construct, indicating that a new 
polyketide was biosynthesized when 2-fluorocinnamyl-CoA and 







The finding that CHS18, together with most type III PKSs, is highly 
promiscuous is quite predictable, given the involvement of these enzymes in 
the generation of secondary metabolites in plants. Some of these metabolites 
can serve as anti-microbial agents, providing the plants with protection against 
harmful microorganisms in the environment (Staunton and Weissman, 2001). 
Others serve as antioxidants, providing another line of defence against threats 
in plants. Hence, it is possible that the promiscuity associated with these 
enzymes will enable the plants to respond quickly to any new threat that 
appears in the environment. This will provide the plant with a survival 
advantage over other members which only harbor PKSs with limited substrate 
selectivities. 
 
2.3.2  Starter acyl-CoA substrate preference of CHS18 
CHS18 was able to use a number of cinnamyl-CoA (Table A2 in 
Appendix), phenylpropanoyl-CoA (Table A2 in Appendix), benzoyl-CoA 
(Table A3 in Appendix), phenylacetyl-CoA (Table A4 in Appendix), bicyclic 
aromatic CoA (Table A4 in Appendix), and saturated and unsaturated aliphatic 
CoA thioester derivatives (Table A5 in Appendix), as the starter substrate, in 
combination with various malonyl-CoA derivatives as the extender substrate 
(Table 2.1). Interestingly, benzoyl-CoA derivatives were the most preferred 
starters (65.8% of the combinations led to new products formed), followed by 
unsaturated aliphatic CoA derivatives (61.7% of the combinations), 
phenylacetyl-CoA derivatives (51.4% of the combinations), cinnamyl-CoA 
derivatives (50% of the combinations), saturated aliphatic CoA derivatives 





combinations), and bicyclic aromatic CoA derivatives (12.5% of the 
combinations). Nevertheless, when the natural extender malonyl-CoA is used, 
the most preferred starters still contain a cinnamyl-CoA backbone, whereby 12 
out of 14 cinnamyl-CoA derivatives tested were accepted by CHS18 to form 
novel polyketides. This is in line with the fact that cinnamyl-CoA and p-
coumaroyl-CoA are natural starter substrates for alfalfa CHS. Hence, it is not 
surprising that due to structural similarities to the cognate substrate, cinnamyl-
CoA derivatives, together with malonyl-CoA, are good substrates for CHS18. 
Amongst the cinnamyl-CoA derivatives, meta-substituted and para-
substituted derivatives were most preferred (62.5% and 60.7% of the 
combinations respectively led to new products formed), compared to ortho-
substituted (25% of the combinations) and aliphatic chain-substituted (45.8% 
of the combinations) derivatives. This suggests that the presence of 
substituents at the ortho position may affect the interaction of the starter unit 
with the active site residues of CHS18, causing ortho-substituted cinnamyl-
CoA derivatives to be accepted less efficiently. This is consistent with 
previous work on alfalfa CHS by Jez and co-workers, which reported that the 
catalytic efficiency of alfalfa CHS is lower when 2-hydroxycinnamyl-CoA is 
used, compared to 3-hydroxycinnamyl-CoA and 4-hydroxycinnamyl-CoA (Jez 
et al., 2002). Interestingly, 2-hydroxyphenylacetyl-CoA (reacted with four out 
of twelve extenders) was also less readily accepted by CHS18 compared to 4-
hydroxyphenylacetyl-CoA (reacted with eight out of twelve extenders), which 
is structurally similar to, but shorter than p-coumaroyl-CoA by a carbon unit.  
Among the para-substituted cinnamyl-CoA derivatives, the OH and CH3O 





products formed), followed by F (58.3% of the combinations), CH3 (25% of 
the combinations), and Cl (16.7% of the combinations) substituent groups. 
This suggests that even though para-substituted cinnamyl-CoA derivatives are 
structurally similar to the natural substrate, the type of substituent in the para 
position can affect the catalytic efficiency of CHS18. The presence of the Cl 
substituent in the para position of cinnamyl-CoA derivatives was the least 
preferred, probably due to huge steric effects which hindered the formation of 
polyketide intermediates in the active site of CHS18.  
When substituent groups are present on the extender acyl-CoA substrate, 
cinnamyl-CoA derivatives are no longer strongly preferred. Instead, smaller 
and more flexible starters like benzoyl-CoA derivatives and unsaturated 
aliphatic CoA derivatives are more easily accepted by CHS18, together with 
unnatural malonyl-CoA derivatives to form unique polyketides (Figure 2.6). 
Most benzoyl-CoA derivatives were utilized as starters, regardless of the 
position of the substituent groups (ortho position: 63.9% of the combinations 
led to new products formed, meta position: 62.5% of the combinations, para 
position: 58.3% of the combinations), suggesting that the benzoyl-CoA 
backbone is small enough to participate in reactions with bulky extenders. As 
for unsaturated aliphatic CoA derivatives, smaller starters with a butenoyl-
CoA backbone were most preferred (70.8% of the combinations led to new 
products formed), followed by those with a pentenoyl-CoA backbone (62.5% 
of the combinations), and those with a hexenoyl-CoA backbone (41.7% of the 
combinations). This is consistent with previous studies on S. baicalensis CHS, 





unfavorable steric effects when additional substituent groups were present in 
the extender acyl-CoA used (Abe et al., 2003). 
 
 
Figure 2.6: Unfavorable steric effects due to bulky extenders like 3-
thiophenemalonyl-CoA (substituent group highlighted in pink) resulted in a 
strong preference for smaller starters like benzoyl-CoA instead of the larger 
cinnamyl-CoA derivatives (starters which formed part of the linear polyketide 
intermediate are highlighted in blue). Hence, the active site cavity of CHS18 
can accommodate benzoyl-CoA derivatives more easily than cinnamyl-CoA 
derivatives, or other more bulky starters. 
 
Surprisingly, other than derivatives of the cognate substrates, CHS18 
could utilize chemically distinct starter acyl-CoAs beyond its canonical 
substrate pool. In particular, it was shown for the first time that CHS18 could 
accept bicyclic aromatic CoA thioesters together with malonyl-CoA 
derivatives to form novel polyketides (6 out of 48 combinations led to new 
products formed). This substrate promiscuity could be attributed to substrate 
mimicry, illustrating how a slight substrate resemblance to the cognate 
substrates can play a role in starter unit recognition in CHS18 and 








Figure 2.7: Structural mimicry of bicyclic aromatic CoA thioesters. The 
mimicry to phenylacetyl-CoA (for 1-naphthalenecarboxyl-CoA) and 
cinnamyl-CoA (for 2-naphthalenecarboxyl-CoA and 2-quinolinecarboxyl-
CoA) are highlighted in blue. 
 
 
2.3.3 Extender acyl-CoA substrate preference of CHS18 
The repertoire of novel polyketides biosynthesized from the 69 x 12 assays 
also provided insights into the extender substrate preference of CHS18. By 
collating the number of starter acyl-CoAs that reacted with each extender 
substrate (Table 2.1), the order of preference for extender acyl-CoA substrates 
for CHS18 was discerned: 3-thiophenemalonyl-CoA > phenylmalonyl-CoA = 
fluoromalonyl-CoA > chloromalonyl-CoA > ethylmalonyl-CoA > malonyl-
CoA > methylmalonyl-CoA > hydroxymalonyl-CoA > butylmalonyl-CoA = 
bromomalonyl-CoA > allylmalonyl-CoA > isopropylmalonyl-CoA. It was 
likely that the extender substrate preference of CHS18 was dependent on the 
stability of the carbanion intermediate generated during catalysis. 
When the extender acyl-CoA enters the active site of CHS18, it is 
decarboxylated to form a carbanion intermediate which can attack the starter 
unit or elongating polyketide bound to the catalytic cysteine residue in the 
active site. This carbanion intermediate is stabilized by resonance effect in all 
the malonyl-CoA derivatives, aided by the nearby His303 and Asn336 
residues (numbering in alfalfa CHS) (Figure 2.8). Certain substituent groups in 





carbanion intermediate. For instance, 3-thiophenemalonyl-CoA and 
phenylmalonyl-CoA were strongly preferred compared to the other extender 
substrates (Table 2.1), perhaps due to the presence of the aromatic ring which 
can confer additional stability via resonance effect (Figure 2.9). Amongst the 
halogen-substituted malonyl-CoA derivatives, the fluoro-substitued malonyl-
CoA derivative has the greatest inductive effect due to the high 
electronegativity of the fluorine atom. Thus, the carbanion intermediate is 
greatly stabilized and fluoromalonyl-CoA is the preferred extender, compared 
to chloromalonyl-CoA and bromomalonyl-CoA.  
 
 
Figure 2.8: Stabilization of the carbanion intermediate after decarboxylation of 





Figure 2.9: Resonance structures depicting the stabilization of the carbanion of 





Compared to the aromatic malonyl-CoA derivatives, the aliphatic 
derivatives such as malonyl-CoA, methylmalonyl-CoA, ethylmalonyl-CoA, 
isopropylmalonyl-CoA, butylmalonyl-CoA, and allylmalonyl-CoA generated 
a smaller range of novel polyketides, each with 21 – 39 starters out of the 69 
starter substrates tested. However, the order of preference did not display a 
significant trend. All in all, by determining the substrate preference of CHS18, 
a library of novel polyketides with potential anti-aging activities could be 
biosynthesized.  
 
2.3.4  Mass spectrometry profiling of novel polyketides 
The substrate profile of CHS18 can be confirmed by determining the mass 
of the polyketide products using MS. Selected combinations of starters and 
extenders were used to generate polyketides in vitro, which were then purified 
by HPLC and sent for MS analysis. Most of the masses of the selected 
polyketides identified in this study matched their corresponding expected 
masses, and the potential chemical structures of the compounds were proposed 
(Table 2.2). Nevertheless, the exact identities of these products are not known 
as NMR analyses are needed. In some cases, cyclization of the polyketide 
intermediate may not occur at all, and the active site cysteine-bound 
intermediate hydrolyzes to form the corresponding acid, which may undergo 
decarboxylation to form a novel polyketide (Figure 2.10). In other cases, some 
of these polyketides could be truncation side products generated from the 
CHS18 reaction which include polyketides with fewer polyketide extension 
steps, or those that are biosynthesized through a lactonization, aldol or Claisen 






Table 2.2: Potential polyketides biosynthesized by CHS18. HPLC retention times are based on analyses conducted using the Atlantis Prep C18 
reverse-phase column. The part of the polyketide derived from the starter unit is highlighted in blue. 
 Combination of 












p-coumaric acid + 
malonic acid 
29.5 272.08 [272.25] C15H12O5 3 
 
Lactonization 
33.7 228.06 [228.24] C14H12O3 3 
 
Aldol 




+ malonic acid 









 Combination of 















+ methylmalonic acid 
13.2 326.10 [326.77] C16H19ClO5 2 
 
None 
26.8 382.12 [382.83] C19H23ClO6 3 
 
None 
Heptanoic acid + 
methylmalonic acid 
42.0 298.22 [298.37] C16H26O5 3 
 
None 
p-coumaric acid + 
ethylmalonic acid 
34.5 356.17 [356.41] C21H24O5 3 
 
Lactonization 









 Combination of 












p-coumaric acid + 
butylmalonic acid 
44.7 218.07 [218.29] C14H18O2 1 
 
Decarboxylation 
p-coumaric acid + 
isopropylmalonic acid 
29.2 354.22 [354.48] C23H30O3 3 
 
Aldol 
33.0 204.05 [204.26] C13H16O2 1 
 
Decarboxylation 
Cinnamic acid + 
allylmalonic acid 
19.0 312.24 [312.36] C19H20O4 2 
 
None 









 Combination of 












p-coumaric acid + 
hydroxymalonic acid 
45.1 222.06 [222.19] C11H10O5 1 
 
None 
p-coumaric acid + 
fluoromalonic acid 
29.6 180.06 [180.18] C10H9FO2 1 
 
Decarboxylation 
p-coumaric acid + 
phenylmalonic acid 
45.0 282.12 [282.29] C17H14O4 1 
 
None 
p-coumaric acid + 
3-thiophenemalonic 
acid 



































As indicated in Table 2.2, most of the new products formed did not 
cyclize, while lactonization was the preferred mode in those polyketides that 
completed cyclization. This was indicative of the ability of CHS18 to elongate 
the polyketide chain, but not perform cyclization in all cases. This is probably 
due to the unfavorable positioning of certain residues of the linear polyketide 
intermediate in the active site due to steric effects, hence aldol condensation 
could not be achieved. Indeed, when the peanut STS was incubated with other 
p-substituted cinnamyl-CoA analogues (-Cl, -Br, and -OCH3), only triketide 
and tetraketide pyrones were obtained, indicating that truncation products are 
common and lactonization had occurred instead of an aldol condensation 
(Morita et al., 2001). This suggested potential steric effects by substituents 
that are larger than that of the wild-type substrate (-OH in p-coumaroyl-CoA 
and -H in malonyl-CoA), which affected the stability and/or the conformation 
of polyketide intermediates in the cyclization pocket of the active site. 
However, as the 12 reactions were only a small subset of the 413 combinations 
which gave rise to new products, it is possible that cyclization may occur with 
other starter and extender combinations.  
Many of the starter and extender substrates used in this research study 
have not been explored in the previous studies, and the product library 
biosynthesized is expected to comprise of novel polyketides with chalcone, 
stilbene, and lactone scaffolds. It has been shown that MS analysis provides an 
idea of the identity of the new products from precursor-directed combinatorial 
biosynthesis. These polyketides can then be further characterized by NMR to 





novel polyketides, the compound library can subsequently be applied to drug 
screening efforts, such as the development of anti-aging therapeutics. 
 
2.3.5 Life span assays using resveratrol or novel polyketides 
Studies on resveratrol have found that it is a potential CR mimetic (Chung 
et al., 2012). By varying the dose of a commercially available resveratrol 
standard used for life span assays on wild-type N2 C. elegans, a significant 
life span extension was observed in worms exposed to 40 μM and 50 μM 
commercially available resveratrol when compared to controls fed with 
DMSO (Figure 2.12). In an attempt to validate the utility of our CHS18 
combinatorial biosynthetic system, 50 μM of biosynthesized resveratrol was 
purified and introduced to wild-type N2 C. elegans, and a significant life span 
extension was also observed when compared to controls fed with DMSO 
(Figure 2.13). However, the amount of increase in life span was not as large as 
when 50 μM commercially available resveratrol was used. Hence this suggests 
that the biosynthesized resveratrol preparation could be slightly impure, and 







Figure 2.12: Survival plots of N2 C. elegans fed with 5 μM, 20 μM, 40 μM, or 
50 μM commercially available resveratrol (green) or DMSO (blue). Worms 
exposed to 50 μM resveratrol had a significantly longer mean life span (27.4 
days) compared to the control (17.1 days). The p-values were calculated using 
log rank test, and a p-value < 0.05 is considered to be statistically significant. 
 
 
Figure 2.13: Survival plots of N2 C. elegans fed with either 50 μM purified 
biosynthesized resveratrol (green) or DMSO (blue). The ‘resveratrol’ 
population had a significantly longer mean life span (15.9 days) compared to 





After establishing the substrate profile of CHS18, the polyketide-
producing CHS18 strain (containing 4CL, MCS and CHS18) and the control 
E. coli strain (containing 4CL and MCS only) were fed to wild-type N2 C. 
elegans separately. Relevant combinations of starter and extender acids were 
incorporated into NGM agar for the biosynthesis of novel polyketides. 24 of 
the 413 novel polyketides were tested for anti-aging properties in a C. elegans 
life span assay (Table 2.3). Most of the tested combinations had no significant 
effects on the wild-type N2 C. elegans except for 3-chlorocinnamyl-CoA + 
malonyl-CoA and 3-(3’-chloro-4’-methoxy)phenylpropanoyl-CoA + 
methylmalonyl-CoA which had toxic effects and led to a shorter life span 
compared to the control (Figure 2.14).  
 
 
Figure 2.14: Survival plots of N2 C. elegans fed with either CHS18 E. coli 
strain (green) or control E. coli strain (blue) supplemented with 3-
chlorocinnamic acid + malonic acid (left) or 3-(3’-chloro-4’-
methoxy)phenylpropanoic acid + methylmalonic acid (right). Worms exposed 
to the novel polyketides produced from these two combinations of starter and 







Table 2.3: Assessing the anti-aging properties of novel polyketides. A (√) 
represents that particular combination was used in the C. elegans life span 
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Interestingly, the mean life spans of the worms treated with the control 
strain and the respective combinations of carboxylic acids were different. For 
instance, worms treated with 3-chlorocinnamic acid, malonic acid, and the 
control E. coli construct had a mean life span of 16.9 days while worms 
treated with 3-(3’-chloro-4’-methoxy)phenylpropanoic acid, methylmalonic 
acid, and the control E. coli construct had a mean life span of 26.5 days. This 
suggests that the acids used or the CoA esters produced could have some 
effects on the life span of wild-type C. elegans. More studies are needed to 
verify the biological effects of these compounds. 
Although the CHS18 strain can produce resveratrol when supplemented 
with p-coumaric acid and malonic acid, a significant life span extension effect 
was not observed (Figure 2.15). This is due to the low concentration of 
resveratrol (approximately 1 μM) biosynthesized by the E. coli constructs 
growing on the NGM agar plates. Nevertheless, studies have shown that 
resveratrol is rapidly metabolized when ingested, and it has a broad spectrum 
of activity in various cellular components such as cyclooxygenases (COX1 
and COX2) and norepinephrine transporters (Cottart et al., 2010; Chung et al., 
2012) in addition to AMPK and sirtuins. Hence, issues of bioavailability and 
adverse effects warrant the need to look for other potential CR mimetics that 
are more potent than resveratrol. Even though the concentration of novel 
polyketides being biosynthesized is low, we hope to identify anti-aging 







Figure 2.15: Survival plots of N2 C. elegans fed with either CHS18 E. coli 
strain (green) or control E. coli strain (blue) supplemented with p-coumaric 
acid and malonic acid. There was no significant difference in the mean life 
span between the two populations, due to the low concentration of resveratrol 
being synthesized by the E. coli constructs. 
 
Despite the utility of life span assays, they are rather time-consuming as 
the average life span of wild-type C. elegans is approximately three weeks at 
20°C. Hence, there is a need to develop a higher throughput method to screen 
our library of compounds for anti-aging properties. Since CR is known to 
promote longevity by modulating oxidative metabolism (Schulz et al., 2007), 
it would be interesting to look at the mitochondrial activity of C. elegans when 
they are exposed to potential CR mimetics. By developing mitochondrial 
function assays, we can screen for anti-aging compounds more efficiently, and 






CHAPTER 3: TOWARDS THE DEVELOPMENT OF NOVEL ANTI-
AGING ALKALOIDS USING PRECURSOR-DIRECTED 
COMBINATORIAL BIOSYNTHESIS 
 
3.1  Introduction 
Alkaloids are the most structurally diverse secondary metabolites, 
providing an untapped potential for the creation of a bioactive compound 
library for anti-aging therapeutic development. Several studies have 
demonstrated the feasibility of performing precursor-directed combinatorial 
biosynthesis using promiscuous type III PKSs to generate novel alkaloids. A 
type III PKS from the club moss Huperzia serrata was found to be able to 
accept a broad range of starter substrates, including N-methylanthraniloyl-
CoA, and synthetic nitrogen-containing starter units like 2-carbamoylbenzoyl-
CoA, to generate novel alkaloids with malonyl-CoA as the extender (Morita et 
al., 2011). Similarly, CHS18 was able to utilize nitrogen-containing starter 
units such as 3-aminobenzoyl-CoA, 4-aminobenzoyl-CoA, and 2-
quinolinecarboxyl-CoA to generate alkaloid products (Tables A3 and A4 in 
Appendix). Hence, this highlights an unconventional and simpler method to 
generate alkaloids by repurposing type III PKSs for alkaloid biosynthesis.  
Since the diversity of the alkaloids biosynthesized by PKSs is partly 
dependent on the starter and extender units, variations in the choice of starters 
and extenders is important. However, there has been a lack of a toolkit that 
describes the means to introduce novel nitrogen-containing acyl-CoA 
precursors to PKSs for alkaloid biosynthesis. As nitrogen-containing acyl-





nitrogen-containing acyl-CoA thioesters from their respective carboxylic acid 
precursors is usually conducted, which involves a slow two-step process 
spanning at least two days. The process encompasses the synthesis of N-
hydroxysuccinimide esters of the respective carboxylic acids, followed by a 
thiol ester exchange reaction with free CoA, to produce CoA thioester 
derivatives (Stockigt and Zenk, 1975) (Figure 3.1). An alternative way to 
generate a wide range of novel nitrogen-containing acyl-CoA esters is to make 
use of promiscuous acid-CoA ligases with different nitrogen-containing 
carboxylic acids. By determining substrate promiscuities of acid-CoA ligases 
and CHS18 beyond conventional substrate pools, we can establish novel 
enzymatic routes for the biosynthesis of unnatural alkaloids with potential 
anti-aging properties. 
 
Figure 3.1: Chemical synthesis of nitrogen-containing acyl-CoA thioesters 
such as 2-carbamoylbenzoyl-CoA from the respective carboxylic acid 
precursors. Each step involves a reaction time of at least 24 h. 
 
Previous studies on MCS, PCL, 4CL, and BZL showed that although they 
can utilize carboxylic acids to generate a total of 81 CoA esters, nitrogen-
containing carboxylic acids were not good substrates (Go et al., 2012). 





availability of genomic DNA in the lab, and putative promiscuous CoA ligase 
functions as annotated in the National Center for Biotechnology Information 
website. The enzyme functions of these acid-CoA ligases were examined 
using a range of nitrogen-containing carboxylic acids, including all 20 
standard amino acids. The new CoA thioesters produced were identified via 
HPLC and MS, and used as substrates for CHS18. By establishing a 
combinatorial biosynthetic pathway involving promiscuous acid-CoA ligases 
and CHS18 (Figure 1.9), a library of unnatural alkaloids with potential anti-






3.2  Materials and methods 
The carboxylic acid substrates for acid-CoA ligases were obtained from 
Sigma-Aldrich Co. (St. Louis, MO, USA), Tokyo Chemical Industry Co. 
(Tokyo, Japan), and Extrasynthese Co. (Genay Cedex, France). A total of 35 
nitrogen-containing carboxylic acids were tested as potential precursors for 
acyl-CoA thioester biosynthesis: 4-nitrocinnamic acid, 3-aminobenzoic acid, 
4-aminobenzoic acid, 4-amino-2-hydroxybenzoic acid, isoquinoline-1-
carboxylic acid, 2-quinolinecarboxylic acid, 2-quinoxalinecarboxylic acid, 3-
quinolinecarboxylic acid, 4-quinolinecarboxylic acid, pyrazine carboxylic 
acid, pyridine-2-carboxylic acid (picolinic acid), pyridine-3-carboxylic acid 
(nicotinic acid), 2-chloropyridine-3-carboxylic acid, pyridine-4-carboxylic 
acid (isonicotinic acid), carnitine, alanine, arginine, asparagine, aspartic acid, 
cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, 
lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, 
tyrosine and valine. All reagents were of the best quality grade that is available 
commercially. The chemical structures of all substrates tested are depicted in 
Figure A6 in the Appendix.  
 
3.2.1  Cloning, expression and purification of novel acid-CoA ligases 
Cg2, Sc1, Sc3, and Ec1 
Putative long chain fatty acid-CoA ligase (Cg2) (GI: 499323704) and 
putative crotonobetaine / carnitine-CoA ligase (Ec1) (GI: 221142682) were 
cloned previously in the laboratory from Corynebacterium glutamicum ATCC 
13032 and E. coli strain K12 MG1655 genomic DNA respectively. Putative 





21218859) were cloned previously in the laboratory from S. coelicolor A3(2) 
genomic DNA. The four CoA ligases were each ligated into a Tom-15b vector 
and expressed in E. coli BL21(DE3) strain. Protein expression and purification 
were conducted as in section 2.2.3. 
 
3.2.2 In vitro biosynthesis of nitrogen-containing acyl-CoA esters 
A small scale reaction involving each nitrogen-containing carboxylic acid 
substrate was first conducted for each of the four acid-CoA ligases in order to 
determine the substrate profiles of the ligases. Biosynthesis of the nitrogen-
containing acyl-CoA thioesters were carried out in 100 µL reaction mixtures 
containing 100 mM Tris-HCL (pH 8.0), 5 mM MgCl2, 5 mM ATP, 5 mM 
CoA, 5 mM nitrogen-containing carboxylic acid, and 2 mg/mL Cg2 / Ec1 / 
Sc1 / Sc3. After incubation for 6 h at 25°C, additional cofactors and CoA 
ligases were added to give a final reaction volume of 200 µL, containing 100 
mM Tris (pH 8.0), 5 mM MgCl2, <5 mM ATP, <5 mM CoA, <5 mM 
nitrogen-containing carboxylic acid, and 2 mg/mL Cg2 / Ec1 / Sc1 / Sc3. The 
reactions were allowed to continue for another 16 h before they were pipetted 
out and centrifuged at 4°C through Amicon Ultracel membranes to remove all 
enzymes from the mixture. The filtrate containing reagents and/or products 
was collected and stored at -80°C until HPLC analysis.  
The Atlantis Analytical C18 reverse-phase column was first equilibrated 
with 1% acetonitrile, 99% 100 mM ammonium acetate (pH 6.5) at a flow rate 
of 1 mL/min for 15 min. 10 µL of sample was loaded and the column was 
washed with 1% acetonitrile, 99% 100 mM ammonium acetate (pH 6.5) at a 





acetonitrile, 30% 100 mM ammonium acetate (pH 6.5) at a flow rate of 1 
mL/min under a linear gradient over a period of 60 min. The eluted 
compounds were detected by measuring the absorbance at 230 nm, 240 nm, 
and 259 nm. New chromatogram peaks (minimum absorbance of 20 mAU) 
other than those due to the ATP, CoA, and carboxylic acid reference standards 
were identified and the respective nitrogen-containing carboxylic acid 
substrate and ligase combinations were scaled up to 2 ml reactions for 
subsequent MS analysis.  
The same reagents were used for the 2 ml reaction mixtures, and 
biosynthesis of the nitrogen-containing acyl-CoA thioesters were conducted in 
a similar manner. In order to purify the novel nitrogen-containing acyl-CoA 
thioesters from the reaction mixture, HPLC analysis was carried out as above 
with minimal changes. The Atlantis Prep C18 reverse-phase column was first 
equilibrated with 1% acetonitrile, 99% 100 mM ammonium acetate (pH 6.5) at 
a flow rate of 5 mL/min for 15 min. Up to 800 µL of sample was loaded and 
the column was washed with 1% acetonitrile, 99% 100 mM ammonium 
acetate (pH 6.5) at a flow rate of 5 mL/min for 4 min. The nitrogen-containing 
acyl-CoA thioesters were eluted with a linear gradient to 70% acetonitrile, 
30% 100 mM ammonium acetate (pH 6.5) over a period of 60 min at a flow 
rate of 5 mL/min. Absorbance was monitored at 230 nm, 240 nm, and 259 nm, 
and fractions containing novel nitrogen-containing acyl-CoA thioesters were 







3.2.3  Kinetic assays of acid-CoA ligase activity 
After verifying that nitrogen-containing acyl-CoA esters were produced by 
the acid-CoA ligases using MS analyses, the kinetic parameters of the ligases 
were determined. Acid-CoA ligase activity was monitored 
spectrophotometrically by coupling the rate of formation of AMP (ligase 
activity) to oxidation of NADH (Figure 3.2) (Go et al., 2012). A 200 μl 
continuous spectrophotometric coupled-enzyme assay containing 100 mM 
Tris-HCL (pH 8.0), 10 mM MgCl2, 5 mM ATP, 1.5 mM phosphoenolpyruvate 
(PEP), 1 mM CoA, 0.16 mM NADH, 2 units of pyruvate kinase, 2 units of 
lactate dehydrogenase, 1 unit of adenylate kinase, varying concentrations of 
carboxylic acid (0.010 – 10 mM), and Cg2 / Ec1 / Sc1 / Sc3 was conducted in 
Quartz cuvettes at 25°C. The reactions were monitored at 340 nm (ε = 6220 
M-1 cm-1) for the oxidation of NADH using a Shimadzu UV-2550 UV-Visible 
Spectrophotometer. Since NADH absorbs at 340 nm, the rate of decrease of 
the absorbance at 340 nm will correlate with the rate of formation of the acyl-
CoA ester. Initial velocity was measured and kinetic parameters were 









Figure 3.2: A continuous spectrophotometric coupled-enzyme assay was used 
to monitor the activities of acid-CoA ligases. Oxidation of NADH can be 
measured at 340 nm. 
 
 
Interestingly, 2-quinoxalinecarboxylic acid can absorb at 340 nm, hence 
acid-CoA ligase activity for this acid was determined using a 5,5'-dithiobis-(2-
nitrobenzoic acid) (DTNB) end-point assay which measures the amount of 
remaining free CoA (Kim and Bang, 1988). Briefly, a 100 μL assay containing 
acid-CoA ligase, 100 mM Tris-HCl (pH 8.0), 10 mM MgCl2, 5 mM ATP, 1 
mM CoA, and varying concentrations of 2-quinoxalinecarboxylic acid (0.01 – 
10 mM) was conducted. After incubation at 25°C for sufficient time to convert 
≤10% of the substrate to product, the reaction was quenched by the addition of 
900 μL of 222 µM DTNB solution. The mixture was incubated at 25°C for 
another 5 min, and the remaining free CoA was quantitated by measuring the 
stoichiometrically equivalent amounts of 2-nitro-5-thiobenzoate dianion at 412 







3.2.4  In vitro precursor-directed combinatorial biosynthesis of alkaloids 
and HPLC analysis 
After verifying the biosynthesis of nitrogen-containing acyl-CoA 
thioesters, the respective carboxylic acid and their ligase were added to 
malonate, MCS and CHS18 for the biosynthesis of novel alkaloids. Initial 
biosyntheses of the nitrogen-containing starter CoA esters and extender CoA 
esters were carried out in 200 µL reaction mixtures containing 100 mM Tris-
HCL (pH 8.0), 10 mM MgCl2, 10 mM ATP, 0.5 mM CoA, 2.5 mM starter 
acid, 5 mM malonic acid, 2 mg/mL Cg2 / Ec1 / Sc1 / Sc3, and 2 mg/mL MCS. 
After incubation for 6 h at 25°C, additional cofactors, CoA ligases, and 2 
mg/mL CHS18 were added to give a final reaction volume of 400 µL, 
containing 100 mM Tris (pH 8.0), 10 mM MgCl2, <10 mM ATP, <0.5 mM 
CoA, <2.5 mM starter acid, <5 mM malonic acid, <0.5 mM starter CoA, <0.5 
mM malonyl-CoA, 2 mg/mL Cg2 / Ec1 / Sc1 / Sc3, 2 mg/mL MCS, and 2 
mg/mL CHS18. Due to the presence of a CoA regeneration system involving 
CoA ligases and CHS18, only a low amount of the expensive CoA is needed 
for the biosynthesis of alkaloids to take place. An aliquot of 80 µL of the 
reaction mixture was immediately pipetted out and centrifuged at 4°C through 
Ultracel membranes to remove all enzymes from the mixture. The filtrate 
(representing time = 0 h) was collected and stored at -80°C until HPLC 
analysis. The remaining 320 µL reaction mixture was then incubated at 25°C 
for another 20 h. Subsequently, enzymes were removed via centrifugation 
through Ultracel membranes, and the filtrate (representing time = 20 h) was 
collected and stored at -80°C until HPLC analysis. HPLC analysis was 





from the 0 h (control) and 20 h (with CHS18) time-points, fractions that were 
only present in the 20 h time-point samples indicate alkaloid biosynthesis. The 
respective nitrogen-containing carboxylic acid substrate, malonic acid, ligases 
and CHS18 combinations were scaled up to 2 ml reactions for subsequent MS 
analysis.  
The same reagents were used for the 2 ml reaction mixtures, and 
biosynthesis of the alkaloids were conducted in a similar manner. In order to 
purify the novel alkaloids from the reaction mixture, HPLC analysis was 
carried out as in section 2.2.4. Absorbance was monitored at 230 nm, 280 nm, 
and 320 nm, and fractions containing novel alkaloids were collected, 
lyophilized, and sent for low-resolution MS analyses. 
 
3.2.5  Mass spectrometry profiling of novel nitrogen-containing acyl-
CoA esters and alkaloids 
MS analysis was conducted under the assistance of our collaborator, Dr. 
Manfred Raida, in A/P Markus Wenk’s laboratory. The lyophilized nitrogen-
containing acyl-CoA thioesters were dissolved in 100 µL deionized water and 
subjected to high-resolution MS scanning and fragmentation. A neutral loss of 
507 m/z was used for identification of the CoA ester group, and the mass of 
the parent ion was analyzed using Masshunter Qualitative Analysis software 







3.3  Results and discussion 
3.3.1  Catalytic functions of Cg2, Sc1, Sc3, and Ec1 
The enzyme functions of the CoA ligases Cg2, Ec1, Sc1, and Sc3 have not 
been determined before. Promiscuity of Cg2, Ec1, Sc1 and Sc3, and the type 
III PKS, CHS18, enabled the biosynthesis of alkaloids when various nitrogen-
containing carboxylic acids were introduced as starters. The diversity of the 
alkaloids generated by CHS18 is dependent on its starter and extender units, 
which are the acyl-CoA thioesters produced by CoA ligases. Hence, there is a 
need to determine the substrate and product profiles of the promiscuous CoA 
ligases before selecting suitable nitrogen-containing carboxylic acid substrates 
for alkaloid biosynthesis. 
Small scale reactions were carried out, whereby the 20 standard amino 
acids and another 15 nitrogen-containing carboxylic acids were introduced 
individually as substrates for Cg2, Ec1, Sc1 and Sc3 in vitro. Out of the 35 
acids tested, the acid-CoA ligases were found to generate a new acyl-CoA 
thioester peak for 14 substrates during HPLC analysis (Table 3.1). For 
instance, when 3-aminobenzoic acid was incubated with Ec1, a new acyl-CoA 
ester peak was observed at an Rt of 26.8 min (Figure 3.3). The reactions for 
the 14 nitrogen-containing carboxylic acids were scaled up and all the new 
peaks detected were purified and verified by MS analysis. Out of the 14 
carboxylic acids tested, only 11 gave a correct and definitive MS result. 2-
quinoxalinecarboxyl-CoA, and the CoA esters of cysteine and glutamic acid 
may be unstable and hence, these products were not detected in the MS 
analysis. The kinetic parameters for the biosynthesis of the various acyl-CoA 






Table 3.1: Low-resolution MS analysis and kinetic parameters for the biosynthesis of new nitrogen-containing acyl-CoA esters. HPLC retention 
times are based on analyses conducted using the Atlantis Prep C18 reverse-phase column. a Saturation kinetics could not be achieved. Italicized: 








Experimental mass of CoA 
ester [theoretical mass] 
kcat (s
-1) KM (mM) kcat/KM (M
-1 s-1) 
 
Cg2 26.4 886.00 [886.65] a a 0.21 
Ec1 26.8 886.10 [886.65] a a 0.35 
 
Cg2 26.2 886.10 [886.65] a a 1.9 
Ec1 26.4 886.10 [886.65] a a 0.037 
 
Cg2 32.0 922.00 [922.69] (1.78 ± 0.06) x 10-3 9 ± 2 0.2 













Experimental mass of CoA 
ester [theoretical mass] 
kcat (s
-1) KM (mM) kcat/KM (M
-1 s-1) 
 
Cg2 30.4 Not detected (1.6 ± 0.1) x 10-3 (15.0 ± 9.8) x 10-3 110 
Sc3 32.0 Not detected 5.5 ± 0.2 0.22 ± 0.03 25000 
Ec1 33.4 922.10 [922.69] (6.0 ± 0.3) x 10-4 0.9 ± 0.2 0.64 
 
Ec1 30.8 837.20 [923.67] a a 0.18 
 













Experimental mass of CoA 
ester [theoretical mass] 
kcat (s
-1) KM (mM) kcat/KM (M
-1 s-1) 
 
Cg2 28.8 922.10 [922.69] (6.7 ± 0.4) x 10-3 0.52 ± 0.09 13 
 
Cg2 23.0 873.10 [873.61] a a 0.16 
 













Experimental mass of CoA 
ester [theoretical mass] 
kcat (s
-1) KM (mM) kcat/KM (M
-1 s-1) 
 
Cg2 23.8 872.00 [872.63] (2.8 ± 0.3) x 10-3 1.7 ± 0.5 1.7 
Ec1 24.2 872.10 [872.63] a a 1.2 x 10-5 
 
Cg2 25.6 907.90 [907.07] (2.0 ± 0.1) x 10-3 1.3 ± 0.3 1.5 
 













Experimental mass of CoA 
ester [theoretical mass] 
kcat (s
-1) KM (mM) kcat/KM (M
-1 s-1) 
 
Ec1 18.4 886.10 [ 870.68] 
Reaction too slow 
to be detected 
Reaction too slow 
to be detected 
Reaction too slow 
to be detected 
Sc1 18.4 886.10 [ 870.68] 
Reaction too slow 
to be detected 
Reaction too slow 
to be detected 
Reaction too slow 
to be detected 
Sc3 18.6 886.10 [ 870.68] a a 22 
 










Figure 3.3: HPLC chromatogram showing the detection of a new acyl-CoA 
thioester peak at an Rt of 26.8 min, when 3-aminobenzoic acid was 
supplemented to Ec1. The identity of the other peaks were determined by 
running commercially available standards using the same HPLC program. 
 
More nitrogen-containing starter carboxylic acids can be tested against the 
four CoA ligases in the future so as to gain more insights into their substrate 
preferences. After verifying the generation of nitrogen-containing starter acyl-
CoA thioesters by MS, precursor-directed combinatorial biosynthesis of 
alkaloids using the promiscuous type III PKS, CHS18, can subsequently be 

























Biosynthesis of new acyl-CoA ester when 3-aminobenzoic 
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3.3.2  Precursor-directed combinatorial biosynthesis is a novel means to 
produce alkaloids 
CHS18 is a promiscuous PKS capable of using unnatural starter and 
extender acyl-CoA esters to biosynthesize novel polyketides. Hence, we 
hypothesized that CHS18 is likely to utilize nitrogen-containing starter units to 
produce alkaloids, and the substrate profile of CHS18 was determined. The 14 
nitrogen-containing carboxylic acids with verified kinetic parameters were 
supplied to CHS18 together with the respective acid-CoA ligases. In addition, 
malonic acid and MCS were introduced to generate the extender, malonyl-
CoA (Figure 3.4). CHS18 was able to catalyze the condensation of malonyl-
CoA with three out of 14 starter acyl-CoA esters separately to form alkaloids. 
When CHS18 was supplemented with 3-aminobenzoyl-CoA generated by 
Ec1, and malonyl-CoA, a new alkaloid peak was observed at an Rt of 20.2 min 
(Figure 3.5). Similarly, CHS18 catalyzed the condensation of malonyl-CoA 
with the 3-aminobenzoyl-CoA thioester produced by Cg2, to form two 
alkaloids with Rt 20.2 min and 30.8 min (Figure 3.6). This could be due to 
different production yields of 3-aminobenzoyl-CoA by Ec1 and Cg2, leading 
to a skewed ratio of starter to extender units, and thus the incorporation of 
different numbers of extender units to form different alkaloid products. The 
combination comprising of 3-quinolinecarboxyl-CoA generated by Ec1 and 
malonyl-CoA also led to the biosynthesis of a new alkaloid product with an Rt 
of 26.0 min by CHS18 (Figure 3.7). Moreover, when pyridine-2-carboxyl-
CoA produced by Cg2 and malonyl-CoA were introduced to CHS18, a new 







Figure 3.4: Precursor-directed combinatorial biosynthesis of novel alkaloids 






Figure 3.5: In vitro precursor-directed combinatorial biosynthesis involving 3-
aminobenzoyl-CoA and malonyl-CoA produced by Ec1 and MCS 
respectively. HPLC analysis was conducted using an Atlantis Analytical C18 
reverse-phase column. An additional peak at Rt 20.2 min was observed when 
CHS18 was incubated with the reagents for 20 h, indicating that a new 






















Biosynthesis of new alkaloid when 3-aminobenzoic acid and malonate 
were added to Ec1, MCS and CHS18 










Figure 3.6: In vitro precursor-directed combinatorial biosynthesis involving 3-
aminobenzoyl-CoA and malonyl-CoA produced by Cg2 and MCS 
respectively. HPLC analysis was conducted using an Atlantis Analytical C18 
reverse-phase column. Additional peaks at Rt 20.2 min and 30.8 min were 
observed when CHS18 was incubated with the reagents for 20 h, indicating 
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Figure 3.7: In vitro precursor-directed combinatorial biosynthesis involving 3-
quinolinecarboxyl-CoA and malonyl-CoA produced by Ec1 and MCS 
respectively. HPLC analysis was conducted using an Atlantis Analytical C18 
reverse-phase column. An additional peak at Rt 26.0 min was observed when 
CHS18 was incubated with the reagents for 20 h, indicating that a new 
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Figure 3.8: In vitro precursor-directed combinatorial biosynthesis involving 
pyridine-2-carboxyl-CoA and malonyl-CoA produced by Cg2 and MCS 
respectively. HPLC analysis was conducted using an Atlantis Analytical C18 
reverse-phase column. An additional peak at Rt 23.1 min was observed when 
CHS18 was incubated with the reagents for 20 h, indicating that a new 
alkaloid was biosynthesized. Pyridine-2-carboxylic acid does not absorb at 
230 nm. 
 
The new peaks were collected and sent for MS analysis. The masses of the 
selected alkaloids identified in this study matched their corresponding 
expected masses, and the potential chemical structures of the compounds were 
proposed (Table 3.2). This suggested the feasibility of utilizing promiscuous 
acid-CoA ligases and non-alkaloid synthases, such as type III PKSs, to 
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Table 3.2: Potential alkaloids biosynthesized by CHS18. The part of the alkaloid derived from the starter unit is highlighted in blue. 















20.2 203.07 [203.19] C11H9NO3 2 
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Variations in the choice of starter and extender CoA esters can facilitate 
the creation of a diverse alkaloid library. Previous studies have shown that 
MCS and PCL are promiscuous enzymes capable of generating several novel 
extenders which are malonyl-CoA derivatives (Go et al., 2012). By using 
CHS18 with different combinations of nitrogen-containing starters and 
malonyl-CoA derivatives, such as isopropylmalonyl-CoA, hydroxymalonyl-
CoA and phenylmalonyl-CoA, a diverse and bioactive library of alkaloids can 
be created. Nitrogen-containing derivatives of malonyl-CoA, such as 2-
[(aminocarbonyl)-amino]-malonyl-CoA and [2-(2-aminophenyl)-hydrazino]-
malonyl-CoA (Figure 3.9), can also be utilized with suitable CoA ligases for 
an added diversity to the alkaloid library. 
 
Figure 3.9: Nitrogen-containing derivatives of malonyl-CoA. The malonyl-
CoA backbone is highlighted in blue. 
 
Previously, CHS18 was derived from alfalfa CHS containing 18 
mutations, and performed a predominantly C2 to C7 Aldol condensation rather 
than a C6 to C1 Claisen condensation, thus allowing CHS18 to acquire STS 
activity (Austin et al., 2004). Manipulation of the type III PKS reactions by 
using rationally engineered mutant enzymes in conjunction with unnatural 





distinct alkaloids. The ‘gatekeeper’ Phe215 is generally conserved in most 
type III PKSs and is located between the CoA-binding tunnel and the entrance 
of the active site cavity. Intriguingly, although N-methylanthraniloyl-CoA is 
not normally utilized by the wild type alfalfa CHS, the F215S mutant was 
found to accept the bulky starter to form N-methylanthraniloyltriacetic acid 
lactone (Jez et al., 2002). A modification into a serine residue at position 215 
results in a reduction in steric hindrance and a wider active site entrance, thus 
allowing the entry of the bulky N-methylanthraniloyl-CoA. This demonstrates 
that mutagenesis studies on CHS18 can be performed to further expand its 
substrate specificity. By rationally incorporating amino acid substitutions, the 
active site cavity of type III PKSs can be altered or expanded to facilitate the 
synthesis of more complex alkaloids in the future. This characteristic makes 
type III PKSs great candidates for structure-based engineering approaches to 
expand the chemical and structural diversity of natural products derived from 
these systems. 
Overall, this study has demonstrated the utility in using precursor-directed 
combinatorial biosynthesis for the production of alkaloids. We can also 
conduct site-directed mutagenesis on residues near the active site cavity of 
CHS18, such as Phe215, so as to increase the product profile of CHS18. By 
constructing a natural product library of both alkaloids and polyketides, 
valuable drug compounds can be obtained more easily compared to extraction 
from natural sources or chemical synthesis. Hence, drug screening efforts, 







CHAPTER 4: MITOCHONDRIAL FUNCTION ASSAY AS A NOVEL 
MEANS TO SCREEN FOR CALORIC RESTRICTION MIMETICS  
 
4.1  Introduction 
Drugs that mimic CR are being developed to improve longevity. These 
include derivatives of the polyketide resveratrol (Gertz et al., 2012) and 
isoquinoline alkaloids such as berberine (Chow and Sato, 2013). The 
conventional method of anti-aging drug screening is via life span assays, 
which are time consuming and impractical to screen for a large compound 
library. Identification of drug hits via microarray profiling is also a feasible 
method (Dhahbi et al., 2005), but it is expensive, invasive and require 
sufficient amount of organ tissue for analysis. Therefore, there is a need to 
develop another high throughput method to screen our library of polyketides 
and alkaloids for anti-aging properties.  
Reduced mitochondrial function and aerobic capacity is one of the 
hallmarks of aging (Lopez-Otin et al., 2013). During the aging process, the 
accumulation of mutations in the nuclear DNA and mitochondrial DNA 
(mtDNA), especially in genes encoding subunits of the ETC, can result in an 
age-related decline in mitochondrial capacity for oxidative phosphorylation 
(Bua et al., 2006; Seo and Leeuwenburgh, 2015). Since CR is known to 
promote longevity by modulating oxidative metabolism (Schulz et al., 2007), 
exposing C. elegans to potential CR mimetics is likely to affect their 





extension, CR, and mitochondrial function, we can design a more effective 
screening assay for CR mimetics with anti-aging properties.  
Resveratrol is able to extend life span in model organisms and is likely to 
be a potential CR mimetic. It is thought to activate AMPK (Um et al., 2010; 
Park et al., 2012) and increase Sirt1-mediated PGC-1α activation (Lagouge et 
al., 2006). Thus, resveratrol-mediated longevity could be due to alterations in 
metabolism. PGC-1α is an important regulator of mitochondrial biogenesis 
and function (Wu et al., 1999). Indeed, resveratrol treatment in mice has been 
shown to improve mitochondrial oxidative phosphorylation and aerobic 
capacity, as evidenced by an induction of genes for mitochondrial content, and 
increased oxygen consumption and physical endurance (Lagouge et al., 2006; 
Um et al., 2010; Park et al., 2012).  
By using resveratrol treatment to mimic CR and establish a reference for 
mitochondrial function assays, screening of potential CR mimetics can be 
facilitated. Mitochondrial function assays using an extracellular flux analyzer 
were adopted to screen for drug hits, in which the real-time mitochondrial 
respiration of C. elegans can be looked into non-invasively at the molecular 
level (Ferrick et al., 2008). In this approach, OCR is used as an indicator of 
metabolic rate, which is considered as the most reliable method of 
determination compared to carbon dioxide production assays and direct 
calorimetry due to size limitations of C. elegans (Braeckman et al., 2002). 
Mitochondrial inhibitors such as carbonyl cyanide p-
(trifluoromethoxy)phenylhydrazone (FCCP), antimycin A and rotenone were 





FCCP is an uncoupling agent which disrupts the proton gradient across the 
inner mitochondrial membrane. This interferes with the generation of ATP as 
protons are transported down a potential gradient back into the mitochondrial 
matrix before being utilized to provide the energy for ATP synthesis (Benz 
and McLaughlin, 1983). This uncoupling of phosphorylation of 5’-Adenosine 
Diphosphate (ADP) from electron transport causes OCR to increase as cells 
attempt to maintain intracellular ATP levels. The greater the increase in OCR 
upon FCCP addition, the more efficient the mitochondria were in producing 
ATP under basal conditions.  
Antimycin A and rotenone inhibit Complex III and Complex I 
respectively, causing the ETC to shut down and result in a decrease in OCR 
below basal levels (Schuh et al., 2012) (Figure 4.1). The introduction of 
FCCP, antimycin A, and rotenone during the mitochondrial function assay 
enables a mitochondrial respiration profile to be generated. This profile allows 
the determination of four mitochondrial respiration parameters, namely basal 
respiration, maximal respiration, spare respiratory capacity, and non-
mitochondrial respiration (Figure 4.1). Future work on screening for CR 
mimetics can be performed by using the mitochondrial respiration profile 
obtained from this study as a reference. This can narrow down the number of 








Figure 4.1: Four parameters of C. elegans mitochondrial respiration can be 
acquired by using mitochondrial inhibitors such as FCCP, antimycin A and 
rotenone to perturb mitochondrial function. FCCP is an uncoupler while 







4.2  Materials and methods 
4.2.1  Optimization of mitochondrial function assays in Caenorhabditis 
elegans 
Mitochondrial function assays were conducted as in Dancy et al. (2013) 
with some modifications. Age-synchronized adult wild-type C. elegans N2 
strain were grown on NGM plates containing 90 µM FUdR, 90 µM FUdR + 
0.1% DMSO, or 90 µM FUdR + 50 µM resveratrol (dissolved in DMSO) for 
different durations up to 14 days, with each treatment having replicates prior 
to the mitochondrial function assay. This is because it has been shown that 
worms exposed to 50 μM resveratrol had a significantly longer mean life span 
compared to worms exposed to DMSO only (Figure 2.11), suggesting that 
resveratrol is a potential CR mimetic at 50 μM.  Oxygen consumption was 
measured using the Seahorse XFe24 Extracellular Flux Analyzer (Seahorse 
Bioscience).  
Briefly, fluorescent probes in 24-well islet microplates were hydrated a 
day before the assay and calibrated just before assays were conducted. C. 
elegans were recovered from NGM plates using M9 minimal medium, and 
washed three times to eliminate eggs and residual bacteria (Dancy et al., 
2013). Worms were transferred to 24-well Seahorse islet plates (10 – 25 
worms in 675 µL M9 minimal medium per well) and covered with an islet 
capture screen. Basal oxygen consumption was measured for 6 cycles before 
performing FCCP treatment at a final concentration of 20 µM. Each cycle of 
reading consisted of a mixing of media for 2 min, waiting for worms to 
equilibrate to the environment for 2 min, and a measurement of oxygen levels 





consumption was subsequently measured for 8 cycles. OCR was then brought 
down to minimal levels by treatment with 20 µM antimycin A and 10 µM 
rotenone.  
OCR values were normalized to the number of worms in each well. 
Kruskal-Wallis test and Dunn’s multiple comparisons test in the GraphPad 
Prism 6 program were used to determine the significance of differences in 
medians. After determining the optimum number of days for exposure to 
potential CR mimetics in order to see any effects on mitochondrial respiration, 
C. elegans were subjected to 25 µM, 40 µM, or 50 µM resveratrol treatment to 
determine any dose-dependent effects on respiration. Mutant eat-2 C. elegans 
which undergo chronic CR, and daf-2 mutants which have compromised IGF-
1 signaling, were also subjected to 50 µM resveratrol treatment, and their 
mitochondrial respiration rates were compared to that of the wild-type N2 
worms. 
 
4.2.2  Screening for more potent caloric restriction mimetics 
After completing the optimization studies, selected compounds in our 
polyketide and alkaloid libraries were introduced to age-synchronized adult 
wild-type C. elegans for eight days. C. elegans were grown on NGM plates 
containing 90 µM FUdR, 0.5 mM starter acids, 1 mM extender acids, 0.1 mM 
IPTG, 34 µg/mL chloramphenicol, 100 µg/mL ampicillin, 30 µg/mL 
kanamycin, and either the corresponding CoA ligases + CHS18 E. coli 
constructs, or constructs without CHS18. E. coli were prepared as in section 





thioesters and novel polyketides / alkaloids were compared to the 
mitochondrial respiration of worms exposed to CoA thioesters only, using 






4.3  Results and discussion 
4.3.1  Optimization of mitochondrial function assays in Caenorhabditis 
elegans  
The development of anti-aging therapeutics involves the generation of a 
diverse bioactive compound library as well as a methodology to screen for 
potential drug hits. These two arms of therapeutic development complement 
each other to enable the discovery of novel bioactive drugs that can lead to life 
span extension in organisms. Mitochondrial function assays were developed 
and optimized in order to establish a correlation between OCR, mitochondrial 
activity, and longevity. 
C. elegans were treated with a CR mimetic, resveratrol, for a range of 
duration before measuring their mitochondrial respiration rates. The results 
were analyzed using Kruskal-Wallis test to determine if there was a significant 
difference in the median OCR of the groups, as the samples were not normally 
distributed. Subsequently, Dunn’s multiple comparisons test was used to 
determine if the medians varied significantly between any two selected 
groups.  
It was observed that C. elegans exposed to 50 µM resveratrol for at least 
seven days have a higher average basal OCR (Figure 4.2) and higher average 
maximal OCR (Figure 4.3) when compared to their controls. However, an 
increase in spare respiratory capacity was only significant after eight days of 
exposure to 50 µM resveratrol (Figure 4.4). This suggests that exposure to a 
potential CR mimetic for at least eight days can counteract the age-related 
decline in mitochondrial function in C. elegans by increasing the average basal 





spare respiratory capacity was indicative of the improvements in the ability of 
the mitochondria to cope with changes in the demand for ATP.  
  
 
Figure 4.2: Average basal OCR readings of C. elegans exposed to (A) 6 days, 
(B) 7 days, (C) 8 days, and (D) 14 days of FUdR + 50 µM resveratrol (Resv). 
Control groups were exposed to FUdR or FUdR + 0.1% DMSO. C. elegans 
exposed to the CR mimetic, resveratrol, for at least seven days have a higher 
rate of average basal respiration as compared to the control. * p-value ≤ 0.05; 







Figure 4.3: Average maximal OCR readings of C. elegans exposed to (A) 6 
days, (B) 7 days, (C) 8 days, and (D) 14 days of FUdR + 50 µM resveratrol 
(Resv). Control groups are the same as in Figure 4.2. C. elegans exposed to 
the CR mimetic, resveratrol, for at least seven days have a higher rate of 
average maximal respiration as compared to the control. * p-value ≤ 0.05; ** 








Figure 4.4: Average spare respiratory capacity of C. elegans exposed to (A) 6 
days, (B) 7 days, (C) 8 days, and (D) 14 days of FUdR + 50 µM resveratrol 
(Resv). Control groups are the same as in Figure 4.2. C. elegans exposed to 
the CR mimetic, resveratrol, for at least eight days have a higher average spare 
respiratory capacity as compared to the control. Hence, an 8-day treatment 
period is optimal for detecting the effects of CR mimetics like resveratrol on 
mitochondrial function. * p-value ≤ 0.05; ** p-value ≤ 0.01; *** p-value ≤ 
0.001. 
 
Our discovery supported a recent study which also observed a rise in C. 
elegans basal mitochondrial respiration rates when resveratrol was introduced 
to the worms (Houtkooper et al., 2013). A likely hypothesis for this intriguing 






shift away from glycolysis towards respiration so as to sustain body function. 
Therefore, there is an elevated electron transport, basal respiration, and ROS 
generation similar to the effects of CR (Lin et al., 2002; Moroz et al., 2014). 
This low exposure to a greater oxidative stress triggers a secondary adaptive 
response called mitohormesis in the host’s defence system, leading to 
improved stress resistance and life span extension (Schulz et al., 2007; Kim et 
al., 2015).  
In addition, the increase in spare respiratory capacity in C. elegans after 
prolonged resveratrol treatment also supported other similar studies in mice, 
whereby the aerobic capacity was improved after a 15-week administration of 
resveratrol (Lagouge et al., 2006). The effect of resveratrol treatment on spare 
respiratory capacity also appeared to mirror that of CR, which has been shown 
to improve spare respiratory capacity in mice fed with 60% of ad libitum diet 
(Cerqueira et al., 2012). This further substantiates the ability of resveratrol to 
function as a CR mimetic in living systems, and supports the use of resveratrol 
as a reference compound to be compared against during drug hit identification 
via mitochondrial function assays after an 8-day treatment. Therefore, this can 
facilitate the screening of potential CR mimetics. The anti-aging properties of 








4.3.2  Establishing a reference mitochondrial function profile using 
resveratrol as a caloric restriction mimetic 
When the dose of resveratrol was varied during the 8-day treatment, both 
40 µM resveratrol and 50 µM resveratrol treatments can elicit an increase in 
basal respiration (Figure 4.5). However, only the 8-day 50 µM resveratrol 
treatment can cause a significant increase in maximal respiration and spare 
respiratory capacity. This suggests a dose-dependent effect of resveratrol on 
mitochondrial function. Since our polyketide and alkaloid library of 
compounds can only be biosynthesized to sub-micro molar amounts by the E. 
coli constructs growing on the NGM agar plates, any identified drug lead from 
mitochondrial function assays will be more potent than resveratrol as a CR 
mimetic. This may help to minimize any adverse effects which are common 








Figure 4.5: Average basal OCR, maximal OCR, and spare respiratory capacity 
of C. elegans exposed to 8 days of FUdR + varying concentrations of 
resveratrol (Resv). Control groups are the same as in Figure 4.2. Dose-
dependent effects of resveratrol are present, and only C. elegans exposed to 50 
µM resveratrol had a significantly higher basal respiration, maximal 
respiration, and spare respiratory capacity compared to controls. * p-value ≤ 
0.05; ** p-value ≤ 0.01. 
 
C. elegans eat-2 mutants have a pharyngeal muscle pumping defect, 
leading to a compromised food intake and allowing mutants to undergo 
chronic CR and subsequently life span extension. Indeed, eat-2 mutants can 
live approximately 38% longer than wild-type C. elegans (Figure 4.6). C. 






maximal respiration, and spare respiratory capacity compared to wild-type 
worms (Figure 4.7). This is consistent with the effects of resveratrol on 
mitochondrial function, highlighting the potential of mitochondrial function 
assays in screening for CR mimetics. Nevertheless, subjecting eat-2 mutants to 
resveratrol treatment did not increase the basal OCR, maximal OCR, and spare 
respiratory capacity further. This suggests that resveratrol may cause a strain 
on the mitochondrial function of the eat-2 mutants which were already 
experiencing chronic CR. Indeed, exposing eat-2 mutants to 50 µM resveratrol 
treatment resulted in a shorter mean life span (15.9 days) compared to eat-2 
mutants which were exposed to 0.1% DMSO (20.0 days) (Figure 4.8). 
Therefore, subjecting the mutants to a further exposure of a CR mimetic may 
result in some detrimental effects on mitochondrial function, leading to a 
shorter life span. 
 
 
Figure 4.6: The mean life span of C. elegans eat-2 mutants (17.6 days) was 







Figure 4.7: Consistent with results using the CR mimetic resveratrol, eat-2 
mutants undergo chronic CR and have a higher basal respiration, maximal 
respiration, and spare respiratory capacity compared to wild-type C. elegans. 
Introducing 50 µM resveratrol to eat-2 mutants does not improve their 
mitochondrial function further. FUdR: worms exposed to FUdR treatment 
only; DMSO: worms exposed to FUdR + DMSO; Resv: worms exposed to 
FUdR + 50 µM resveratrol. * p-value ≤ 0.05; ** p-value ≤ 0.01; *** p-value ≤ 









Figure 4.8: The mean life span of C. elegans eat-2 mutants subjected to 50 µM 
resveratrol treatment (15.9 days) was significantly shorter than the mean life 
span of C. elegans eat-2 mutants subjected to 0.1% DMSO treatment only 
(20.0 days). 
 
Resveratrol was found to activate AMPK and sirtuins, resulting in PGC-1α 
activation and increasing mitochondrial biogenesis and respiration rate 
(Lagouge et al., 2006; Um et al., 2010; Gertz et al., 2012; Park et al., 2012). 
CR on the other hand, can activate AMPK and sirtuins while inhibiting the 
IGF-1 and mTOR pathways (Kenyon, 2010; Moroz et al., 2014). Interestingly, 
C. elegans daf-2 mutants, which have compromised IGF-1 signaling and also 
live longer compared to wild-type worms, do not have the same improvement 
in mitochondrial function as eat-2 mutants or wild-type worms subjected to 
CR mimetic treatment (Figure 4.9). This is in contrast to previous studies 
which found daf-2 mutants to have a higher basal respiration than wild-type 
worms (Houthoofd et al., 2005). This could be due to the fact that daf-2 
mutants are approximately 37% smaller in volume compared to wild-type 






worms rather than worm number. However, normalizing metabolic data to 
protein content can still be inaccurate as the true amount of metabolically 
active mass is always unknown (Braeckman et al., 2002).  
 
 
Figure: 4.9: C. elegans daf-2 mutants seem to have a lower basal respiration, 
maximal respiration, and spare respiratory capacity compared to eat-2 and 
wild-type C. elegans. Introducing 50 µM resveratrol to eat-2 and daf-2 
mutants does not improve their mitochondrial function further. FUdR: worms 
exposed to FUdR treatment only; DMSO: worms exposed to FUdR + DMSO; 
Resv: worms exposed to FUdR + 50 µM resveratrol. * p-value ≤ 0.05; ** p-







Nevertheless, the results also show that daf-2 mutants are resistant to the 
effects of resveratrol, since subjecting daf-2 mutants to resveratrol treatment 
failed to improve their mitochondrial function further. This suggests that CR 
mimetics may act partly through the insulin/IGF-1 pathway too. A recent 
study on mouse intestinal fibroblasts found that resveratrol can inhibit the 
binding of IGF-1 to its receptor, in addition to activating Sirt1 (Li et al., 2014). 
More studies are needed to investigate the actual mechanisms of resveratrol, 
so as to validate whether CR biochemical pathways are indeed targeted. 
All in all, sufficient evidence has pointed to the fact that resveratrol can 
mimic some aspects of CR, and can extend the life span of several model 
organisms, although the detailed mechanism of action is still unknown. Using 
the OCR profile of wild-type C. elegans exposed to 8 days of 50 µM 
resveratrol, and the OCR profile of eat-2 mutants as references, we can screen 
our library of polyketides and alkaloids for potential CR mimetics. A 
molecular screening platform where novel compound libraries are screened in 
C. elegans-based mitochondrial function assays is thus developed. 
 
4.3.3  Screening for more potent caloric restriction mimetics 
Since life span assays are not efficient in screening for anti-aging 
compounds, E. coli constructs and selected combinations of starters and 
extenders leading to the biosynthesis of novel polyketides or alkaloids were 
supplemented to C. elegans, and their mitochondrial function was analyzed 
using an extracellular flux analyzer. This will serve as a higher-throughput 






compounds, which have a similar metabolic flux profile to resveratrol. Due to 
time constraint, only a few novel polyketides and alkaloids from our 
compound library were tested, and none of them significantly improved the 
mitochondrial function of wild-type C. elegans.  
For instance, when ethylmalonic acid and p-coumaric acid were 
incorporated into the NGM agar together with either the control or the CHS18 
E. coli construct, N2 worms exposed to the novel polyketides, ethylmalonyl-
CoA, and p-coumaroyl-CoA did not have a significantly higher basal 
respiration, maximal respiration, and spare respiratory capacity compared to 
worms exposed to the CoA esters only (Figure 4.10). Similarly, worms 
exposed to the novel polyketides, butylmalonyl-CoA, and p-coumaroyl-CoA 
did not have a significantly higher basal respiration, maximal respiration, and 
spare respiratory capacity compared to worms exposed to the CoA esters only 
(Figure 4.11). Also, when malonic acid and the nitrogen-containing 3-
aminobenzoic acid were incorporated into the NGM agar together with the 
respective E. coli constructs, worms exposed to the novel alkaloids, malonyl-
CoA, and 3-aminobenzoyl-CoA did not have a significantly higher basal 
respiration, maximal respiration, and spare respiratory capacity compared to 
worms exposed to the CoA esters only (Figure 4.12).  
Interestingly, either the carboxylic acids used or the CoA esters produced 
by the ligases seem to increase the respiration of N2 worms when compared to 
worms exposed to FUdR only. This is similar to the conclusions derived from 
life span assays, whereby N2 worms exposed to the control E. coli construct 
and certain combinations of carboxylic acids had a longer life span compared 






different combination of acids (Figure 2.13). However, when N2 worms were 
treated with 1 mM butylmalonic acid and 0.5 mM p-coumaric acid only in 
NGM agar with OP50 E. coli as the food source, the basal respiration, 
maximal respiration, and spare respiratory capacity were not significantly 
improved compared to worms exposed to FUdR only (Figure 4.13). This rules 
out any potential effect on mitochondrial function that is due to an exposure to 
a low dose of carboxylic acids. More studies are needed to find out whether 
the CoA esters indeed play a role in affecting the mitochondrial function of C. 
elegans. All in all, by developing mitochondrial function assays, we can 
screen our libraries for anti-aging compounds more efficiently. 
 
 
Figure 4.10: Ethylmalonic acid and p-coumaric acid were incorporated into 
NGM agar together with either the control (Ctrl) or CHS18 E. coli construct. 
C. elegans exposed to novel polyketides and CoA esters produced by the 
CHS18 E. coli construct (contains CoA ligases + CHS18) do not have a higher 
basal respiration, maximal respiration, and spare respiratory capacity 
compared to C. elegans exposed to CoA esters only (control construct contains 
CoA ligases only). FUdR: worms exposed to FUdR treatment only. * p-value 









Figure 4.11: Butylmalonic acid and p-coumaric acid were incorporated into 
NGM agar together with either the control (Ctrl) or CHS18 E. coli construct. 
C. elegans exposed to novel polyketides and CoA esters produced by the 
CHS18 E. coli construct (contains CoA ligases + CHS18) do not have a higher 
basal respiration, maximal respiration, and spare respiratory capacity 
compared to C. elegans exposed to CoA esters only (control construct contains 
CoA ligases only). FUdR: worms exposed to FUdR treatment only. **** p-









Figure 4.12: Malonic acid and 3-aminobenzoic acid were incorporated into 
NGM agar together with either the control (Ctrl) or CHS18 E. coli construct. 
C. elegans exposed to novel alkaloids and CoA esters produced by the CHS18 
E. coli construct (contains CoA ligases + CHS18) do not have a higher basal 
respiration, maximal respiration, and spare respiratory capacity compared to 
C. elegans exposed to CoA esters only (control construct contains CoA ligases 
only). FUdR: worms exposed to FUdR treatment only. *** p-value ≤ 0.001; 
**** p-value ≤ 0.0001. 
 
 
Figure 4.13: C. elegans exposed to p-coumaric acid and butylmalonic acid 
only do not have a higher basal respiration, maximal respiration, and spare 
respiratory capacity compared to C. elegans exposed to FUdR only. *** p-







CHAPTER 5: FUTURE DIRECTIONS IN ANTI-AGING 
NUTRACEUTICAL DEVELOPMENT AND CONCLUSION  
 
Ever since the discovery of the first “longevity gene”, age-1, in C. elegans, 
there has been a steady progress in understanding how we age, hence allowing 
us to develop strategies to counter the effects of aging. CR is currently still the 
best means to achieve a longer and healthier life span, but it is difficult to have 
the discipline to adhere to such a rigorous intervention. Furthermore, there 
could be side effects like depression and hypotension. By studying the biology 
of aging and targeting the biochemical pathways affected by CR without 
restricting calorie intake, it is hoped that maximal life span can one day be 
increased and bring upon a reduction in the severity of age-related diseases 
like cancer and diabetes. However, we first need a library of potential drug 
compounds and an effective screening platform, before we can embark on the 
journey to develop anti-aging drug leads. 
Since the diversity of the compounds biosynthesized by PKSs is partly 
dependent on the starter and extender units, variations in the choice of starters 
and extenders is important. However, combinatorial biosynthesis is limited by 
the means to introduce novel acyl-CoA precursors to PKSs for the 
biosynthesis of novel compounds. Precursor-directed combinatorial 
biosynthesis using CoA ligases and a type III PKS, CHS18 was demonstrated 
to be a viable approach that can be utilized for the biosynthesis of novel 
polyketides. By using a combination of 69 starters and 12 extenders, the 
diversity and complexity of the polyketides produced were enhanced, and at 
least 413 unnatural polyketides were generated. As the crystal structures of 






Bank (PDB), more rational approaches of structure-based engineering can be 
adopted in addition to precursor-directed combinatorial biosynthesis, for the 
production of more novel polyketides. This strategy is advantageous because 
other than the choice of starter and extender, the number of rounds of 
polyketide chain extension and the intramolecular mode of cyclization of the 
linear polyketide intermediate can affect the diversity of the polyketide 
produced. By incorporating choice mutations into the active site cavity of the 
PKS, polyketide chain elongation and the cyclization mode of the intermediate 
can be modified.  
In fact, a recent report demonstrated that although octaketides are not 
usually synthesized by the wild type S. baicalensis CHS, the S338V mutant 
CHS was found to produce trace amounts of SEK4 and SEK4b using eight 
units of malonyl-CoA (Abe et al., 2006). This S338V mutation was proposed 
to facilitate the extension of the linear polyketide intermediate into a buried 
pocket in the active site cavity of the enzyme by providing steric guidance. 
Therefore, it was demonstrated for the first time that CHS could be engineered 
to generate longer polyketides such as octaketides. This suggests that rational 
site-directed mutagenesis efforts can be used to generate PKSs with different 
substrate selectivities and altered product profiles, thereby producing more 
diverse novel polyketides.  
Yields of certain target compounds can also be increased by conducting 
site-directed mutagenesis on CHS18 to find mutants with better activity. A 
previous study in our lab showed that a S341N mutation in a chalcone 
synthase from Oryza sativa led to an improved yield of a tetraketide pyrone 






2015). Hence, we can also carry out a similar mutation in CHS18 to increase 
the activity of CHS18 and subsequently, the yield of various products. 
Since the polyketides only contribute to a relatively small group of natural 
products, the project was extended to look into the biosynthesis of other 
natural product classes such as the alkaloids, which are also known to possess 
important biological activities. Therefore, the precursor-directed combinatorial 
biosynthesis of novel natural products was expanded by testing more nitrogen-
containing substrates and looking into the substrate specificities of more CoA 
ligases. This allows the introduction of novel nitrogen-containing acyl-CoA 
precursors to PKSs for alkaloid biosynthesis, highlighting a unique and 
simpler method to generate a large library of novel alkaloids. CHS18 was able 
to catalyze the condensation of malonyl-CoA with three out of 14 nitrogen-
containing starter acyl-CoA esters separately to form alkaloids. The next step 
will be to test the nitrogen-containing starters with the rest of the 11 malonyl-
CoA derivatives in order to produce a library of bioactive alkaloids. We can 
also look into the biosynthesis of other natural product classes such as 
isoprenoids, so as to further enrich our compound library for anti-aging drug 
screening. 
After developing a substantial library of novel compounds, we then 
focused on the development of an efficient screening platform for anti-aging 
drug hits. Since life span assays are time consuming and not practical for 
screening a huge compound library, mitochondrial function assays were used 
as sufficient evidence has pointed to a link between metabolism, CR mimetics, 
and anti-aging. Although a consensus has not been reached regarding the exact 






physiological shift towards respiration away from glycolysis in order to 
maintain body function. This leads to a small increase in ROS production and 
causes an elevated and improved oxidative stress response via mitohormesis, 
enabling the host to better counteract the effects of aging and live longer.  
In fact, many studies have continually disproved the mitochondrial free 
radical theory of aging and an increase in ROS is viewed as a consequence 
rather than a cause of aging (Lagouge and Larsson, 2013). ROS are now 
viewed as important mediators and signaling molecules of the stress response 
to age-associated damage. This explains why many antioxidant therapies have 
failed to delay the progression of age-associated diseases and extend life span 
in clinical trials.  
On the other hand, CR in C. elegans has been shown to induce catalase 
enzyme activity and improve oxidative stress resistance, resulting in a longer 
life span (Schulz et al., 2007). Further research by other researchers (Lagouge 
et al., 2006; Moroz et al., 2014) and this study led to the conclusion that life 
span, mitochondrial function, CR and CR mimetics are intricately linked. By 
supplying our compound library to C. elegans for eight days and looking at 
their respiration rates and mitochondrial function, we can quickly narrow 
down potential CR mimetics without having to go through a lengthy life span 
assay.  
Beyond the in vivo screening, additional evaluation of in vivo effects are 
necessary. Reduced body temperature, lower plasma insulin levels, increased 
mitochondrial biogenesis, and enhanced protection against oxidative stress are 






is identified through mitochondrial function assays, it will be useful to test the 
compound in mice or rats and evaluate the effects on these biomarkers, in 
addition to mitochondrial function and toxicity studies.  
Once we have identified a promising anti-aging drug lead with minimal 
adverse effects, we can either use the drug directly in humans or incorporate 
the combinatorial biosynthetic pathway into a probiotic strain such as E. coli 
Nissle 1917. Hence, in addition to preventing diseases of the gastrointestinal 
tract, the probiotic Nissle strain can lead to a stable biosynthesis of anti-aging 
drugs within the human host. More research still needs to be done, and 
currently we are building a combinatorial biosynthetic pathway involving 
phenylalanine ammonia lyase (PAL) as an enzyme upstream of the CoA 
ligases and CHS18. PAL is able to deaminate phenylalanine and tyrosine to 
cinnamic acid and coumaric acid respectively, while 4CL can utilize these 
carboxylic acids to produce starter acyl-CoAs for CHS18 for the biosynthesis 
of potential anti-aging compounds. Nutraceuticals are food or parts of food 
that provide health or medical benefits such as the prevention or treatment of 
diseases (De and Ghosh, 2012). It will be very interesting if we can make use 
of nutraceuticals such as an engineered strain of E. coli Nissle to deliver anti-
aging compounds constantly to the body. 
Nevertheless, as drug candidates undergo different validation assessments, 
it is important to note that aging is a complex process affecting different 
biochemical pathways, macromolecules, organelles and tissues. There are nine 
hallmarks of aging which are interconnected and we have only focused mainly 
on interventions targeting deregulated nutrient sensing and mitochondrial 






may lie in a ‘cocktail’ of drug compounds rather than a single drug approach. 
This study is a primer towards the development of therapeutic drugs in the 
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Table A1: Carboxylic acids and the corresponding CoA ligases used for the 
precursor-directed combinatorial biosynthesis of polyketides. 






-H Malonic acid MCS 
-CH3 Methylmalonic acid MCS 
 Ethylmalonic acid MCS 
 
Isopropylmalonic acid MCS 
 Butylmalonic acid MCS 
 
Allylmalonic acid MCS 
-OH Hydroxymalonic acid MCS 
-F Fluoromalonic acid MCS 
-Cl Chloromalonic acid MCS 
-Br Bromomalonic acid MCS 
 
Phenylmalonic acid PCL 
 
3-thiophenemalonic acid PCL 
  




None Cinnamic acid 4CL 
R2: -F 2-fluorocinnamic acid 4CL 
R3: -F 3-fluorocinnamic acid 4CL 
R4: -F 4-fluorocinnamic acid 4CL 
R1: -F α-fluorocinnamic acid 4CL 






R4: -Cl 4-chlorocinnamic acid 4CL 
R2: -OH 2-hydroxycinnamic acid 4CL 






R4: -OCH3 4-methoxycinnamic acid 4CL 
R4: -CH3 4-methylcinnamic acid 4CL 








Table A1 (continued) 
Phenylpropanoate 
type 




































None Benzoic acid BZL 
R1: -F 2-fluorobenzoic acid BZL 
R2: -F 3-fluorobenzoic acid BZL 
R3: -F 4-fluorobenzoic acid BZL 
R1: -F 
R5: -F 
2,6-difluorobenzoic acid BZL 
R1: -Cl 2-chlorobenzoic acid BZL 
R2: -Cl 3-chlorobenzoic acid BZL 
R3: -Cl 4-chlorobenzoic acid BZL 
R1: -Br 2-bromobenzoic acid BZL 
R2: -Br 3-bromobenzoic acid BZL 
R3: -Br 4-bromobenzoic acid BZL 
R1: -I 2-iodobenzoic acid BZL 
















R1: -OCH3 2-methoxybenzoic acid BZL 
R1: -CH3 2-methylbenzoic acid BZL 
R2: -NH2 3-aminobenzoic acid BZL 








Table A1 (continued) 


















None Phenoxyacetic acid PCL 
 








1 Propanoic acid BZL 
2 Butanoic acid BZL or PCL 
3 Pentanoic acid PCL 
4 Hexanoic acid 4CL 
5 Heptanoic acid 4CL 
6 Octanoic acid 4CL 
7 Nonanoic acid 4CL 








Table A1 (continued) 
Unsaturated aliphatic type Starter carboxylic acid CoA ligase used 
 
2-butenoic acid BZL 
 
2-methyl-2-butenoic acid BZL 
 
3-methyl-2-butenoic acid BZL 
 
3-butenoic acid BZL 
 
2-pentenoic acid BZL 
 
3-pentenoic acid PCL 
 
4-pentenoic acid BZL 
 
3-methyl-4-pentenoic acid PCL 
 
3-hexenoic acid PCL 
 
5-hexenoic acid PCL 
 
Naphthalene and quinoline 
type 










2-quinolinecarboxylic acid 4CL 
 










Figure A1: Biosynthesized products in spent minimal medium containing 
either E. coli with CoA ligases + CHS18 or E. coli with CoA ligases only 
(control construct) were extracted and subjected to HPLC analysis. An 
additional peak at Rt 27.3 min was observed in the extract from the CHS18 
construct, but was not present in the extract from the control construct, 
indicating that a new polyketide was biosynthesized when 3-chlorocinnamyl-
CoA and malonyl-CoA were supplemented to CHS18. 
 
 
Figure A2: Biosynthesized products in spent minimal medium containing 
either E. coli with CoA ligases + CHS18 or E. coli with CoA ligases only 
(control construct) were extracted and subjected to HPLC analysis. Additional 
peaks at Rt 13.2 min and 26.8 min were observed in the extract from the 
CHS18 construct, but were absent in the extract from the control construct, 
indicating that new polyketides were biosynthesized when 3-(3’-chloro-4’-









Figure A3: Biosynthesized products in spent minimal medium containing 
either E. coli with CoA ligases + CHS18 or E. coli with CoA ligases only 
(control construct) were extracted and subjected to HPLC analysis. An 
additional peak at Rt 42.0 min was observed in the extract from the CHS18 
construct, but was not present in the extract from the control construct, 
indicating that a new polyketide was biosynthesized when heptanoyl-CoA and 
methylmalonyl-CoA were supplemented to CHS18. 
 
 
Figure A4: Biosynthesized products in spent minimal medium containing 
either E. coli with CoA ligases + CHS18 or E. coli with CoA ligases only 
(control construct) were extracted and subjected to HPLC analysis. Additional 
peaks at Rt 29.2 min and 33.0 min were observed in the extract from the 
CHS18 construct, but were not present in the extract from the control 
construct, indicating that new polyketides were biosynthesized when p-









Figure A5: Biosynthesized products in spent minimal medium containing 
either E. coli with CoA ligases + CHS18 or E. coli with CoA ligases only 
(control construct) were extracted and subjected to HPLC analysis. An 
additional peak at Rt 45.0 min was observed in the extract from the CHS18 
construct, but was absent in the extract from the control construct, indicating 
that a new polyketide was biosynthesized when p-coumaroyl-CoA and 3-










Table A2: Substrate profile of CHS18 involving 12 extender acyl-CoAs with cinnamyl-CoA and phenylpropanoyl-CoA derivatives as starters. 
For cinnamyl-CoA derivatives as starters, 84 out of 168 combinations (50.0%) produced at least one new product, while 19 out of 84 
combinations (22.6%) produced at least one new product for phenylpropanoyl-CoA derivatives as starters. A (√) represents at least one new 
product is formed. Extender acyl-CoAs are abbreviated as follows: malonyl-CoA (Mal), methylmalonyl-CoA (MeMal), ethylmalonyl-CoA 
(EtMal), isopropylmalonyl-CoA (IsoMal), butylmalonyl-CoA (ButMal), allylmalonyl-CoA (AlMal), hydroxymalonyl-CoA (OHMal), 
fluoromalonyl-CoA (FMal), chloromalonyl-CoA (ClMal), bromomalonyl-CoA (BrMal), phenylmalonyl-CoA (PhMal), and 3-thiophenemalonyl-
CoA (3ThMal). 
Substrate Mal MeMal EtMal IsoMal ButMal AlMal OHMal Fmal ClMal BrMal PhMal 3ThMal 
Cinnamic acid √     √ √ √ √    
2-fluorocinnamic acid √ √      √   √ √ 
3-fluorocinnamic acid √ √ √  √  √  √ √ √  
4-fluorocinnamic acid √ √      √ √ √ √ √ 
α-fluorocinnamic acid        √ √    
3-chlorocinnamic acid √ √      √     
3-chloro-4-methoxycinnamic acid √   √ √ √  √ √ √ √ √ 
4-chlorocinnamic acid √       √     
2-hydroxycinnamic acid           √  
4-hydroxycinnamic acid √  √ √ √  √ √ √ √ √ √ 
3-methoxy-4-hydroxycinnamic acid √  √ √ √  √ √ √ √ √ √ 
4-methoxycinnamic acid √   √ √ √ √ √ √ √ √ √ 
4-methylcinnamic acid √    √ √       
α-methylcinnamic acid √  √ √ √   √ √ √ √ √ 
3-phenylpropanoic acid √ √ √       √ √  
3-(3’-chloro)phenylpropanoic acid √ √           
3-(3’-chloro-4’-methoxy)phenylpropanoic acid  √           
3-(3’,4’-dihydroxy)phenylpropanoic acid       √      
3-(3’-methoxy)phenylpropanoic acid  √           
3-(4’-methoxy)phenylpropanoic acid  √ √    √ √ √ √   
3-(4’-fluoro)phenylpropanoic acid √ √     √      








Table A3: Substrate profile of CHS18 involving 12 extender acyl-CoAs with benzoyl-CoA derivatives as starters. 158 out of 240 combinations 
(65.8%) produced at least one new product. A (√) represents at least one new product is formed. Extender acyl-CoAs are abbreviated as follows: 
malonyl-CoA (Mal), methylmalonyl-CoA (MeMal), ethylmalonyl-CoA (EtMal), isopropylmalonyl-CoA (IsoMal), butylmalonyl-CoA (ButMal), 
allylmalonyl-CoA (AlMal), hydroxymalonyl-CoA (OHMal), fluoromalonyl-CoA (FMal), chloromalonyl-CoA (ClMal), bromomalonyl-CoA 
(BrMal), phenylmalonyl-CoA (PhMal), and 3-thiophenemalonyl-CoA (3ThMal). 
   
Substrate Mal MeMal EtMal IsoMal ButMal AlMal OHMal Fmal ClMal BrMal PhMal 3ThMal 
Benzoic acid  √ √  √ √ √ √ √  √ √ 
2-fluorobenzoic acid √ √ √ √ √ √ √ √ √ √ √ √ 
3-fluorobenzoic acid √ √ √ √  √ √ √ √ √ √ √ 
4-fluorobenzoic acid √ √ √ √    √ √ √ √ √ 
2,6-difluorobenzoic acid   √ √ √ √ √ √ √ √ √ √ 
2-chlorobenzoic acid  √ √  √ √ √ √ √  √ √ 
3-chlorobenzoic acid  √ √ √ √ √ √ √ √ √ √ √ 
4-chlorobenzoic acid √  √ √ √   √ √ √  √ 
2-bromobenzoic acid √  √  √  √ √ √  √ √ 
3-bromobenzoic acid  √ √  √ √ √ √ √ √  √ 
4-bromobenzoic acid   √   √  √ √  √ √ 
2-iodobenzoic acid √  √  √  √ √ √  √ √ 
2-hydroxybenzoic acid        √ √  √ √ 
2,3-dihydroxybenzoic acid        √ √   √ 
2,4-dihydroxybenzoic acid     √ √  √ √  √ √ 
2,5-dihydroxybenzoic acid √       √ √   √ 
2-methoxybenzoic acid √  √ √ √ √  √ √  √ √ 
2-methylbenzoic acid   √  √ √ √ √ √ √ √ √ 
3-aminobenzoic acid √    √ √  √ √  √ √ 
4-aminobenzoic acid   √    √ √ √  √ √ 








Table A4: Substrate profile of CHS18 involving 12 extender acyl-CoAs with phenylacetyl-CoA and bicyclic aromatic CoA derivatives as 
starters. For phenylacetyl-CoA derivatives as starters, 37 out of 72 combinations (51.4%) produced at least one new product, while 6 out of 48 
combinations (12.5%) produced at least one new product for bicyclic aromatic CoA derivatives as starters. A (√) represents at least one new 
product is formed. Extender acyl-CoAs are abbreviated as follows: malonyl-CoA (Mal), methylmalonyl-CoA (MeMal), ethylmalonyl-CoA 
(EtMal), isopropylmalonyl-CoA (IsoMal), butylmalonyl-CoA (ButMal), allylmalonyl-CoA (AlMal), hydroxymalonyl-CoA (OHMal), 









Substrate Mal MeMal EtMal IsoMal ButMal AlMal OHMal Fmal ClMal BrMal PhMal 3ThMal 
Phenylacetic acid √ √  √ √ √   √ √ √ √ 
2-hydroxyphenylacetic acid  √     √    √ √ 
4-hydroxyphenylacetic acid  √ √ √  √  √ √  √ √ 
4-methoxyphenylacetic acid √       √  √ √ √ 
Phenoxyacetic acid  √        √ √ √ 
Phenylpyruvic acid √ √      √ √ √ √ √ 
1-naphthalenecarboxylic acid            √ 
2-naphthalenecarboxylic acid √  √        √ √ 
2-quinolinecarboxylic acid          √   
3-quinolinecarboxylic acid             








Table A5: Substrate profile of CHS18 involving 12 extender acyl-CoAs with saturated and unsaturated aliphatic CoA derivatives as starters. For 
unsaturated aliphatic CoA derivatives as starters, 74 out of 120 combinations (61.7%) produced at least one new product, while 35 out of 96 
combinations (36.5%) produced at least one new product for saturated aliphatic CoA derivatives as starters. A (√) represents at least one new 
product is formed. Extender acyl-CoAs are abbreviated as follows: malonyl-CoA (Mal), methylmalonyl-CoA (MeMal), ethylmalonyl-CoA 
(EtMal), isopropylmalonyl-CoA (IsoMal), butylmalonyl-CoA (ButMal), allylmalonyl-CoA (AlMal), hydroxymalonyl-CoA (OHMal), 












Substrate Mal MeMal EtMal IsoMal ButMal AlMal OHMal Fmal ClMal BrMal PhMal 3ThMal 
Propanoic acid   √     √ √  √ √ 
Butanoic acid √ √ √ √ √ √ √ √ √ √ √ √ 
Pentanoic acid  √         √ √ 
Hexanoic acid √  √          
Heptanoic acid √ √ √ √   √ √  √   
Octanoic acid   √   √       
Nonanoic acid   √         √ 
Decanoic acid   √         √ 
2-butenoic acid  √     √ √ √  √ √ 
2-methyl-2-butenoic acid √  √ √ √ √ √ √    √ 
3-methyl-2-butenoic acid   √ √ √ √ √ √ √ √ √ √ 
3-butenoic acid √ √ √ √ √  √ √ √  √ √ 
2-pentenoic acid √ √ √ √ √ √ √ √ √ √  √ 
3-pentenoic acid  √ √        √ √ 
4-pentenoic acid  √ √ √ √ √ √ √ √ √ √ √ 
3-methyl-4-pentenoic acid  √ √        √ √ 
3-hexenoic acid √ √ √        √ √ 
5-hexenoic acid  √ √      √  √ √ 
















Figure A6: Nitrogen-containing carboxylic acids used for determining 
substrate profiles of CoA ligases. 
